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1.	  Background	  
1.1	  Macrophage	  role	  in	  the	  immune	  response	  
Macrophages,	  as	  a	  primary	  cell	  of	  the	  innate	  immune	  system,	  serve	  many	  physiological	  functions	  such	  as	  maintaining	  homeostasis,	  tissue	  repair,	  and	  the	  immune	  response,	  and	  these	  cells	  also	  play	  a	  role	  in	  various	  disease	  states.	  	  These	  hematopoietic	  cells	  are	  phagocytic	  in	  nature	  and	  are	  found	  in	  all	  mammalian	  tissues,	  with	  a	  wide	  array	  of	  activation	  states	  that	  result	  in	  a	  variety	  of	  function	  [1].	  These	  different	  activation	  states	  have	  been	  shown	  to	  span	  a	  wide	  spectrum	  of	  function[2,	  3],	  but	  the	  classical	  nomenclature	  divides	  macrophage	  phenotypes	  into	  two	  broad	  categories,	  termed	  M1	  and	  M2,	  based	  on	  the	  classification	  of	  T-­‐helper	  cell	  responses	  [4].	  	  These	  overarching	  M1	  and	  M2	  macrophage	  categories	  indicate	  whether	  a	  macrophage	  is	  primarily	  pro-­‐inflammatory	  or	  anti-­‐inflammatory	  respectively.	  	  Dysregulation	  in	  macrophage	  activation	  has	  been	  implicated	  in	  a	  variety	  of	  disease	  states,	  including	  cancer	  [5,	  6],	  fibrosis	  [1,	  7],	  chronic	  wounds	  [8,	  9],	  obesity	  [10-­‐12],	  and	  many	  others	  [13].	  	  In	  chronic	  wounds	  in	  particular,	  it	  has	  been	  shown	  that	  the	  wound	  may	  remain	  in	  a	  pro-­‐inflammatory	  state	  for	  an	  extended	  period	  of	  time,	  prolonging	  the	  wound	  and	  delaying	  healing	  [8].	  	  Thus,	  a	  method	  for	  characterizing	  macrophage	  behavior	  in	  human	  tissue	  is	  necessary	  in	  order	  to	  understand	  the	  spectrum	  of	  their	  behavior,	  and	  to	  develop	  targeted	  treatments.	  	  However,	  not	  only	  can	  macrophage	  phenotype	  be	  heterogeneous	  in	  an	  environment,	  but	  the	  samples	  obtained	  in	  studying	  these	  disease	  states,	  and	  chronic	  wounds	  in	  particular,	  are	  also	  heterogeneous.	  The	  samples	  contain	  many	  cell	  types,	  and	  so	  isolating	  macrophage	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behavior	  in	  this	  complex	  environment	  is	  challenging.	  	  Both	  flow	  cytometry	  and	  immunohistological	  staining	  approaches	  have	  been	  implemented	  to	  characterize	  heterogeneous	  samples,	  but	  those	  methods	  face	  drawbacks	  when	  using	  clinical	  samples.	  Those	  drawbacks	  include	  the	  need	  for	  live	  cells	  for	  staining,	  difficult	  optimization	  for	  staining,	  and	  in	  the	  case	  of	  flow	  cytometry,	  the	  need	  for	  costly	  equipment	  and	  specifically	  trained	  personnel.	  	  We	  have	  chosen	  here	  to	  rely	  on	  gene	  expression	  to	  understand	  phenotype	  identity,	  as	  gene	  expression	  demonstrates	  real-­‐time	  changes	  as	  the	  cell	  responds	  to	  its	  environment,	  but	  also	  can	  be	  done	  after	  cells	  have	  been	  lysed	  and	  frozen	  for	  long	  periods	  of	  time	  as	  it	  does	  not	  require	  staining	  or	  samples	  for	  optimization	  of	  staining.	  
As	  macrophages	  play	  an	  important	  role	  in	  many	  disease	  states,	  their	  characterization	  has	  been	  the	  subject	  of	  study	  for	  many	  years.	  	  Macrophages	  work	  in	  conjunction	  with	  the	  other	  cells	  of	  the	  immune	  system,	  and	  so	  these	  studies	  have	  often	  included	  analysis	  of	  heterogeneous	  tissues.	  Macrophage	  phenotype	  has	  been	  characterized	  using	  a	  variety	  of	  methods	  in	  these	  situations.	  	  One	  group,	  whose	  goal	  was	  to	  assess	  whether	  there	  was	  a	  phenotype	  change	  in	  adipose	  tissue	  macrophages	  in	  mice	  with	  a	  high-­‐fat	  diet	  vs.	  those	  in	  normal	  diets,	  used	  flow	  cytometry	  with	  pan-­‐macrophage	  markers	  to	  isolate	  macrophages	  from	  their	  heterogeneous	  adipose	  tissue	  samples	  [12].	  	  They	  then	  used	  gene	  expression	  to	  assess	  both	  M1	  and	  M2	  markers	  in	  obese	  and	  lean	  mice	  in	  those	  isolated	  macrophages.	  This	  two	  step	  process	  would	  allow	  for	  an	  understanding	  of	  increased	  or	  decreased	  M1	  or	  M2	  presence	  in	  a	  heterogeneous	  sample,	  but	  assumes	  that	  both	  phenotypes	  were	  equally	  likely	  to	  be	  isolated	  in	  the	  first	  flow	  cytometry	  step,	  and	  requires	  the	  cells	  to	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be	  alive	  prior	  to	  staining,	  which	  is	  not	  always	  possible	  when	  collecting	  and	  storing	  clinical	  samples.	  	  This	  method	  of	  isolating	  macrophages	  and	  then	  characterizing	  the	  isolated	  sample	  has	  been	  used	  in	  other	  studies	  as	  well	  [14].	  	  Another	  group	  with	  the	  same	  goal	  of	  characterizing	  macrophages	  in	  adipose	  tissue	  analyzed	  whole	  adipose	  tissue	  and	  used	  expression	  of	  macrophage	  markers	  CD68	  and	  CD14	  to	  approximate	  the	  number	  of	  macrophages	  in	  the	  sample	  [11].	  	  They	  determined	  phenotypic	  changes	  by	  looking	  at	  the	  expression	  of	  phenotype	  markers	  relative	  to	  CD14	  expression,	  and	  reported	  consistent	  results	  when	  normalizing	  to	  CD68	  as	  well.	  However,	  depending	  on	  the	  composition	  of	  the	  sample,	  this	  could	  be	  affected	  by	  additional	  cell	  types	  expressing	  high	  levels	  of	  pro	  or	  anti-­‐inflammatory	  genes,	  or	  if	  CD68	  and	  CD14	  expression	  are	  not	  equally	  expressed	  between	  the	  macrophages	  present	  in	  the	  sample.	  	  
Specifically	  looking	  at	  characterizing	  macrophages	  in	  the	  wound	  environment,	  similar	  approaches	  have	  been	  implemented.	  	  Several	  groups	  isolated	  macrophages	  from	  a	  suspension	  of	  wound	  cells	  using	  magnetic	  cell	  separation	  techniques,	  and	  then	  characterized	  phenotypes	  via	  cell	  staining	  and	  flow	  cytometry	  [15,	  16].	  	  However,	  these	  approaches	  that	  physically	  isolate	  cell	  types	  have	  several	  technical	  limitations,	  such	  as	  availability	  of	  surface	  markers,	  and	  the	  process	  itself	  may	  impact	  the	  cells	  so	  as	  to	  alter	  gene	  expression	  [17].	  Additionally,	  it	  can	  be	  difficult	  to	  obtain	  the	  required	  volume	  of	  cells	  for	  such	  analysis	  from	  variable	  clinical	  samples.	  A	  second	  group	  seeking	  to	  determine	  relative	  cell	  type	  proportions	  in	  murine	  wound	  samples	  used	  histological	  characterization	  methods,	  which	  while	  this	  approach	  was	  successful	  in	  inferring	  the	  count	  of	  neutrophils,	  macrophages,	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and	  endothelial	  cells,	  it	  did	  not	  distinguish	  the	  macrophage	  phenotypes.	  	  The	  group	  then	  did	  a	  whole	  genome	  microarray	  analysis	  of	  the	  wound	  tissue	  to	  identify	  up-­‐regulated	  genes,	  and	  from	  that	  point,	  mined	  the	  up-­‐regulated	  genes	  for	  cell-­‐type	  specific	  markers,	  but	  again	  did	  not	  parse	  out	  specific	  macrophage	  phenotype	  distinctions	  [18].	  	  Thus,	  a	  method	  for	  efficiently	  inferring	  the	  relative	  composition	  of	  macrophage	  phenotype	  within	  a	  heterogeneous	  environment	  is	  necessary	  to	  understand	  how	  their	  behavior	  may	  affect	  not	  only	  wound	  healing,	  but	  also	  in	  many	  other	  potential	  disease	  progressions.	  
1.2	  Deconvolution	  of	  heterogeneous	  tissue	  samples	  
Our	  motivation	  in	  pursuing	  deconvolution	  of	  heterogeneous	  samples	  stems	  from	  our	  prior	  studies	  characterizing	  macrophages	  in	  heterogeneous	  environments,	  particularly	  macrophage	  behavioral	  changes	  over	  time	  in	  chronic	  diabetic	  foot	  ulcers	  [8].	  	  	  In	  this	  study,	  wound	  tissue	  was	  collected	  from	  patient	  ulcers	  weekly	  over	  a	  period	  of	  time,	  and	  the	  tissue	  was	  assessed	  for	  expression	  of	  M1	  and	  M2	  macrophage	  markers,	  and	  the	  ratio	  of	  expression	  between	  those	  two	  phenotypes	  was	  used	  to	  predict	  healing	  vs.	  non-­‐healing.	  	  While	  this	  predictive	  ratio	  demonstrated	  high	  accuracy	  with	  data	  from	  ten	  patients,	  these	  markers	  are	  not	  macrophage	  specific.	  	  If	  the	  knowledge	  gained	  from	  this	  study,	  that	  prolonged	  M1	  marker	  expression	  delays	  healing,	  is	  to	  be	  useful	  in	  treatment	  strategies,	  an	  understanding	  of	  the	  source	  of	  that	  expression	  is	  necessary.	  	  Because	  this	  study	  design	  results	  in	  numerous	  samples	  per	  patient,	  a	  deconvolution	  method	  would	  need	  to	  be	  both	  cost	  and	  time	  efficient,	  and	  be	  able	  to	  handle	  variable	  sample	  size.	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Thus,	  we	  have	  designed	  a	  model	  to	  predict	  relative	  M1/M2	  sample	  composition	  based	  on	  targeted	  expression	  of	  genes	  that	  are	  both	  differentially	  expressed	  between	  the	  phenotypes,	  and	  not	  highly	  expressed	  in	  other	  cell	  types	  present	  in	  the	  wound	  environment.	  	  	  
Two	  general	  approaches	  have	  been	  taken	  to	  characterize	  gene	  expression	  of	  heterogeneous	  samples.	  	  	  One	  method	  involves	  cell	  sorting	  to	  look	  at	  expression	  on	  a	  single	  cell	  basis,	  which	  loses	  the	  potential	  to	  gain	  a	  systems	  perspective,	  while	  the	  other	  analyzes	  gene	  expression	  in	  heterogeneous	  tissue	  without	  any	  cellular	  context,	  which	  can	  provide	  relevant	  information	  but	  does	  not	  allow	  knowledge	  of	  the	  expression	  source	  [19].	  	  In	  order	  to	  overcome	  the	  difficulties	  present	  in	  characterizing	  cell	  types	  in	  heterogeneous	  tissue	  samples,	  many	  methods	  of	  deconvolution	  have	  been	  implemented	  [19,	  20].	  	  Computational	  deconvolution	  exists	  in	  the	  center	  of	  these	  two	  approaches.	  	  It	  can	  provide	  information	  about	  the	  cell	  source	  of	  expression	  without	  losing	  the	  potential	  to	  gain	  system	  level	  information	  due	  to	  the	  isolation	  of	  specific	  cell	  types,	  and	  without	  having	  to	  perturb	  the	  cells	  through	  that	  isolation	  process	  [19].	  	  If	  cell	  types	  are	  isolated,	  the	  ability	  to	  assess	  the	  tissue	  sample	  as	  a	  whole	  is	  lost,	  and	  as	  it	  is	  unlikely	  that	  all	  possible	  cell	  types	  are	  able	  to	  be	  isolated	  from	  the	  sample,	  that	  systems	  level	  information	  could	  not	  be	  reconstructed	  computationally	  post-­‐isolation.	  Additionally,	  single	  cell	  analysis	  is	  impractical	  for	  samples	  that	  are	  collected	  in	  a	  clinical	  setting,	  due	  to	  the	  challenges	  with	  immediately	  processing	  the	  samples.	  There	  have	  been	  multiple	  implementations	  of	  deconvolution,	  varying	  in	  the	  types	  of	  input	  and	  output	  they	  produce.	  	  All	  methods	  begin	  with	  data	  generated	  from	  heterogeneous	  samples,	  and	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additionally	  require	  gene	  markers,	  signatures,	  or	  cell	  proportions	  to	  predict	  cell	  presence,	  relative	  composition,	  enriched	  cell	  types,	  or	  to	  estimate	  cell-­‐type	  specific	  signatures.	  The	  majority	  of	  these	  methods	  seek	  to	  predict	  cell	  type	  presence	  from	  whole	  genome	  data	  such	  as	  microarray	  or	  RNA-­‐sequencing	  (RNA-­‐seq)	  [19,	  20].	  	  These	  methods	  have	  obtained	  good	  accuracy,	  but	  require	  a	  large	  amount	  of	  prior	  knowledge,	  and	  incur	  the	  cost	  of	  whole	  genome	  sequencing.	  	  	  
A	  wide	  variety	  of	  both	  mathematical	  and	  statistical	  learning	  models	  have	  been	  used	  in	  the	  implemented	  solutions.	  	  These	  range	  from	  quadratic	  programming	  [21],	  Bayesian	  frameworks	  [22],	  linear	  mixture	  models	  [23],	  probabilistic	  graphs	  [24],	  or	  gene	  set	  enrichment	  scores	  [25].	  There	  are	  approaches	  that	  implement	  a	  specific	  mathematical	  framework	  to	  model	  cell-­‐type	  expression	  based	  on	  input,	  and	  then	  there	  are	  machine	  learning	  techniques	  which	  use	  a	  method	  to	  determine	  how	  best	  to	  model	  the	  data	  without	  any	  predetermined	  mathematical	  framework,	  and	  have	  previously	  been	  implemented	  in	  the	  classification	  of	  cell	  types	  [26].	  	  These	  methods	  determine	  the	  best	  fit	  based	  on	  training	  data	  consisting	  of	  known	  inputs	  and	  known	  outputs,	  and	  accuracy	  can	  be	  assessed	  via	  holding	  out	  a	  part	  of	  the	  training	  data	  to	  test	  the	  proposed	  fit	  and	  then	  applying	  the	  best	  fit	  to	  entirely	  new	  data.	  	  A	  model	  that	  is	  accurate	  in	  both	  of	  these	  stages	  can	  then	  be	  used	  to	  predict	  unknown	  output.	  	  Of	  specific	  interest	  here	  are	  neural	  networks	  (NN)	  and	  support	  vector	  machines	  (SVM).	  	  NNs	  take	  a	  specified	  number	  of	  inputs	  and	  pass	  that	  information	  through	  a	  various	  number	  of	  nodes	  with	  weights	  determined	  by	  the	  training	  data.	  	  The	  number	  of	  node	  layers	  in	  between	  the	  input	  and	  output	  can	  vary.	  	  The	  weights	  for	  each	  node	  are	  optimized	  using	  the	  training	  data,	  thus	  allowing	  the	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data	  to	  determine	  the	  node	  weights	  that	  are	  most	  accurate	  in	  modeling	  the	  problem	  [27].	  	  SVMs	  fit	  a	  curve	  that	  is	  able	  to	  separate	  the	  data	  based	  on	  known	  outputs,	  and	  the	  data	  points	  closest	  to	  the	  curve,	  the	  support	  vectors,	  determine	  that	  fit.	  	  If	  the	  data	  is	  not	  linearly	  separable,	  the	  algorithm	  will	  transform	  the	  data	  using	  a	  kernel	  equation,	  until	  it	  can	  be	  separated	  [28].	  	  
	   Computational	  deconvolution	  has	  been	  applied	  to	  heterogeneous	  tissue	  samples	  previously,	  though	  the	  majority	  of	  applications	  require	  whole	  genome	  sequencing	  data	  as	  input,	  and	  require	  prior	  information	  from	  purified	  cell	  types	  that	  would	  be	  present	  in	  heterogeneous	  samples	  [19].	  	  One	  method	  of	  particular	  relevance	  is	  ESTIMATE	  -­‐	  Estimation	  of	  STromal	  and	  Immune	  cells	  in	  MAlignant	  Tumours	  using	  Expression	  data	  [25].	  This	  method	  uses	  gene	  expression	  markers	  for	  cell	  types	  to	  extract	  the	  proportion	  of	  stromal	  and	  immune	  cells	  in	  heterogeneous	  tumor	  samples.	  	  This	  group	  began	  by	  identifying	  genes	  common	  in	  tumor	  samples	  across	  publicly	  available	  sets,	  and	  then	  filtered	  these	  sets	  down	  to	  determine	  signatures	  for	  stromal	  and	  immune	  cells	  within	  this	  environment.	  	  These	  signatures	  were	  used	  to	  determine	  a	  stromal	  score,	  an	  immune	  score,	  and	  then	  an	  overall	  tumor	  purity	  score.	  	  Single	  sample	  gene	  set	  enrichment	  analysis	  (ssGSEA)	  of	  those	  established	  signatures	  was	  used	  to	  determine	  the	  enrichment	  score	  of	  for	  stromal	  cells	  and	  immune	  cells	  in	  whole	  genome	  heterogeneous	  data,	  and	  then	  those	  scores	  were	  combined	  to	  produce	  a	  tumor	  purity	  score.	  While	  this	  method	  was	  able	  to	  identify	  the	  relative	  enrichment	  of	  immune	  cells	  and	  stromal	  cells	  in	  tumor	  samples	  to	  determine	  infiltration,	  it	  did	  not	  provide	  the	  resolution	  necessary	  to	  determine	  the	  specific	  cell	  types,	  or	  their	  respective	  phenotypes,	  involved	  in	  that	  infiltration.	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Another	  group	  created	  a	  digital	  sorting	  algorithm	  that	  followed	  a	  similar	  pipeline.	  	  They	  identified	  genes	  highly	  expressed	  in	  certain	  cell	  types	  from	  publicly	  available	  data	  and	  used	  those	  to	  fit	  a	  linear	  model	  capable	  of	  estimating	  cell	  type	  frequencies	  in	  mixed	  tissue	  samples,	  and	  then	  extrapolated	  this	  approach	  to	  include	  an	  estimation	  of	  tissue	  specific	  frequencies	  as	  well	  [17].	  	  We	  build	  on	  this	  prior	  work	  here	  by	  increasing	  resolution	  to	  reveal	  cell-­‐type	  specific	  phenotypes	  beyond	  only	  cell	  type	  without	  requiring	  whole	  genome	  analysis,	  and	  in	  using	  multiple	  models	  with	  training	  data	  to	  create	  both	  donor-­‐specific	  models	  when	  a	  standard	  curve	  can	  be	  created	  in	  vitro,	  and	  models	  that	  incorporate	  multiple	  donors	  and	  can	  be	  applied	  to	  samples	  where	  standard	  curve	  creation	  is	  not	  possible.	  A	  similar	  process	  as	  in	  both	  of	  these	  prior	  studies	  for	  establishing	  gene	  signatures	  to	  be	  used	  in	  deconvolution	  was	  applied	  for	  this	  project.	  	  	  
Many	  other	  methods	  for	  deconvolution	  have	  been	  proposed,	  the	  majority	  of	  which	  seek	  to	  extract	  cell	  type	  proportions	  from	  whole	  genome	  data.	  	  Two	  relevant	  pipelines	  have	  been	  summarized	  above	  and	  have	  informed	  the	  approach	  used	  here,	  but	  a	  summary	  of	  available	  computational	  methods	  for	  deconvolution	  of	  whole	  genome	  data	  into	  cell-­‐type	  frequencies	  is	  available	  [19,	  20].	  	  Many	  of	  these	  approaches	  use	  mathematical	  models	  fit	  to	  known	  gene	  signatures	  to	  infer	  cell	  type	  frequency	  from	  heterogeneous	  data.	  	  Linear	  models	  are	  commonly	  used,	  as	  well	  as	  Bayesian	  or	  probabilistic	  frameworks	  [20].	  	  We	  expand	  on	  the	  previous	  work	  here	  by	  creating	  a	  model	  based	  not	  on	  whole	  genome	  data,	  but	  targeted	  gene	  expression	  values	  obtained	  via	  RT-­‐PCR,	  and	  in	  the	  incorporation	  of	  machine	  learning	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approaches,	  namely	  support	  vector	  regression	  and	  neural	  networks,	  to	  infer	  a	  model	  fit.	  
Learning	  methods	  have	  been	  previously	  used	  to	  gain	  insight	  into	  cell	  type	  phenotypes.	  	  One	  group	  implemented	  a	  variety	  of	  machine	  learning	  approaches	  with	  the	  goal	  of	  classifying	  dendritic	  cell	  phenotypes	  based	  on	  gene	  expression	  values.	  	  They	  used	  a	  similar	  protocol	  as	  described	  above	  to	  identify	  genes	  useful	  in	  classification,	  and	  then	  used	  both	  model	  learning	  and	  functional	  gene	  selection	  to	  further	  refine	  the	  list.	  	  They	  then	  inputted	  expression	  values	  of	  these	  genes	  into	  several	  different	  learning	  models,	  including	  several	  used	  here,	  such	  as	  logistic	  regression	  and	  support	  vector	  machines,	  though	  they	  also	  implemented	  other	  models	  useful	  in	  classification.	  	  These	  models	  produced	  accuracies	  ranging	  from	  65.3%	  to	  95.9%	  when	  performing	  on	  validation	  data,	  with	  support	  vector	  machines	  providing	  the	  best	  accuracy.	  	  This	  was	  achieved	  with	  a	  signature	  consisting	  of	  three	  genes	  to	  classify	  the	  phenotypes	  into	  two	  groups	  –	  inflammatory	  and	  not	  inflammatory	  [26].	  We	  expand	  on	  this	  work	  by	  incorporating	  continuous	  regression	  predictions	  that	  provide	  insight	  into	  the	  relative	  composition	  of	  an	  entire	  sample,	  rather	  than	  a	  binary	  classification.	  
Motivated	  by	  our	  analysis	  of	  macrophage	  behavior	  over	  time	  in	  wound	  tissue	  samples	  obtained	  from	  a	  clinical	  setting,	  we	  have	  determined	  a	  need	  for	  an	  efficient	  method	  to	  determine	  the	  relative	  composition	  of	  macrophage	  phenotype	  in	  those	  samples.	  	  This	  information	  will	  allow	  for	  a	  better	  understanding	  of	  the	  role	  of	  macrophages	  in	  the	  wound	  healing	  process.	  	  This	  understanding	  will	  inform	  the	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design	  of	  treatment	  strategies	  that	  target	  macrophages	  with	  the	  goal	  of	  modulating	  their	  behavior	  to	  induce	  healing.	  
2.	  Overview	  of	  Aims	  
The	  overall	  goal	  of	  designing	  a	  predictive	  model	  that	  would	  output	  the	  M1/M2	  composition	  ratio	  of	  a	  heterogeneous	  sample	  based	  on	  targeted	  gene	  expression	  was	  divided	  into	  three	  aims:	  
Aim	  1:	  Identify	  genes	  capable	  of	  revealing	  macrophage	  specific	  behavior	  in	  wounds.	  
Aim	  2:	  Design	  a	  predictive	  model	  that	  outputs	  relative	  composition	  of	  a	  heterogeneous	  sample	  based	  on	  gene	  expression.	  
Aim	  3:	  Characterize	  macrophage	  behavior	  in	  relevant	  scenarios.	  
3.	  Criteria	  and	  Constraints	  
In	  order	  for	  the	  designed	  model	  to	  meet	  the	  established	  need	  discussed	  above,	  several	  criteria	  were	  established	  with	  which	  to	  assess	  the	  design.	  	  Accuracy	  metrics	  for	  other	  composition	  determination	  methods,	  namely	  flow	  cytometry,	  were	  assessed.	  	  Findings	  from	  previous	  studies	  indicated	  that	  acceptable	  accuracy	  rates	  for	  determining	  cell	  populations	  within	  a	  sample	  using	  flow	  cytometry	  fell	  within	  a	  +/-­‐	  15%	  range	  [29],	  and	  produced	  results	  that	  had	  a	  Pearson	  correlation	  coefficient	  of	  at	  least	  r	  =	  0.9	  with	  values	  obtained	  from	  a	  gold	  standard	  [29,	  30].	  	  For	  this	  reason,	  the	  criteria	  for	  determining	  success	  included	  accuracy	  within	  15%	  of	  the	  known	  ratio,	  and	  a	  Pearson	  correlation	  of	  at	  least	  r	  =	  0.9,	  or	  an	  R2	  =	  0.81,	  with	  known	  sample	  composition,	  which	  is	  defined	  as	  the	  fraction	  of	  M1	  cells	  in	  the	  sample.	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Additionally,	  constraints	  were	  established	  to	  ensure	  the	  proposed	  solution	  overcomes	  limitations	  present	  in	  current	  methods,	  such	  as	  flow	  cytometry	  or	  RNA-­‐seq.	  	  The	  proposed	  method	  should	  have	  flexibility	  in	  sample	  input,	  which	  includes	  not	  needing	  live	  cells,	  such	  as	  in	  methods	  that	  require	  staining.	  It	  should	  incur	  a	  cost	  less	  than	  that	  of	  RNA-­‐seq,	  at	  $365.00/sample	  for	  20	  million	  reads,	  as	  an	  example	  from	  ABM,	  an	  Illumina	  Certified	  Service	  Provider,	  and	  this	  does	  not	  including	  any	  bioinformatics	  analysis,	  which	  would	  further	  increase	  the	  price.	  	  It	  should	  require	  equipment	  less	  expensive	  than	  a	  flow	  cytometer,	  which	  can	  range	  in	  price	  depending	  on	  options	  and	  can	  be	  in	  excess	  of	  $100,000,	  from	  BD	  Biosciences.	  	  A	  comparison	  of	  the	  potential	  solutions	  is	  shown	  in	  Table	  1.	  
Table	  1.	  Ranking	  of	  potential	  solutions	  for	  criteria	  (1	  is	  lowest)	  
Potential	  Solution	   Cost	   Efficiency	   Accuracy	   Ease	  of	  Use	   Sum	  Flow	  cytometry	   3	   4	   4	   3	   13	  Whole	  transcriptome	  computational	  deconvolution	   2	   2	   4	   2	   10	  Immunohistological	  staining	   3	   2	   2	   1	   8	  Targeted	  gene	  expression	   4	   4	   4	   5	   17	  	  
The	  proposed	  solution	  to	  meet	  these	  criteria	  within	  the	  constraints	  is	  to	  identify	  a	  gene	  signature	  for	  each	  macrophage	  phenotype	  and	  use	  targeted	  expression	  of	  those	  genes	  to	  predict	  the	  relative	  composition	  of	  the	  phenotypes	  within	  the	  heterogeneous	  sample.	  Fulfillment	  of	  accuracy	  criteria	  was	  assessed	  at	  each	  stage	  of	  model	  development,	  but	  the	  constraints	  regarding	  sample	  type	  and	  cost	  were	  assessed	  in	  determining	  the	  mechanism	  for	  characterizing	  the	  cells.	  	  Typical	  total	  RNA	  yield	  from	  100	  mg	  of	  skin	  tissue	  is	  20	  ug,	  and	  about	  3%	  of	  that	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RNA	  is	  mRNA	  [31].	  Each	  sample	  per	  gene	  for	  our	  RT-­‐PCR	  protocol	  requires	  20	  ng	  of	  cDNA,	  assuming	  a	  1:1	  conversion	  from	  mRNA.	  	  Thus,	  for	  assessing	  expression	  of	  one	  gene,	  0.33	  mg	  of	  tissue	  is	  required	  per	  sample.	  Additionally,	  this	  approach	  allows	  for	  the	  cells	  to	  be	  lysed	  and	  stored	  for	  a	  long	  period	  of	  time	  prior	  to	  analysis,	  which	  is	  ideal	  for	  time	  course	  collection	  of	  clinical	  samples.	  	  The	  average	  cost	  of	  RT-­‐PCR	  with	  SYBR®	  Green	  per	  sample	  per	  reaction	  is	  in	  the	  range	  of	  $0.56	  [32],	  and	  so	  when	  compared	  to	  RNA-­‐seq	  at	  $365.00/sample,	  assuming	  duplicates	  for	  each	  sample	  will	  raise	  the	  cost	  to	  $1.12,	  about	  326	  genes	  could	  be	  assessed	  for	  the	  same	  price,	  far	  more	  than	  we	  propose	  here.	  
4.	  Aim	  1:	  Identify	  genes	  capable	  of	  revealing	  macrophage	  specific	  behavior	  
4.1	  Experimental	  Design	  
Publicly	  available	  data,	  as	  well	  as	  RNA-­‐seq	  data	  from	  M1	  and	  M2	  macrophages	  generated	  in	  our	  lab,	  was	  used	  to	  determine	  a	  list	  of	  potential	  markers	  for	  each	  phenotype.	  	  This	  was	  done	  to	  establish	  markers	  that	  were	  consistently	  differentially	  expressed	  in	  a	  number	  of	  experimental	  environments	  by	  independent	  researchers,	  and	  across	  various	  platforms.	  	  These	  markers	  were	  then	  assessed	  for	  expression	  in	  other	  cell	  types	  present	  in	  the	  wound	  environment,	  both	  at	  baseline	  and	  during	  an	  immune	  response,	  to	  ensure	  they	  are	  primarily	  expressed	  in	  macrophages.	  	  This	  was	  done	  using	  a	  combination	  of	  publicly	  available	  experimental	  data	  through	  the	  Human	  Protein	  Atlas	  and	  NCBI,	  as	  well	  as	  through	  publicly	  available	  datasets	  looking	  at	  various	  wound	  cell	  types	  both	  in	  injury	  and	  non-­‐injury	  situations.	  	  The	  final	  marker	  list	  for	  each	  phenotype	  was	  verified	  in	  an	  additional	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publicly	  available	  dataset	  to	  ensure	  that	  the	  M1	  genes	  were	  more	  highly	  expressed	  in	  the	  M1	  samples	  from	  that	  dataset,	  and	  same	  for	  the	  M2	  gene	  list.	  
4.2	  Methods	  
In	  order	  to	  compile	  genes	  that	  are	  differentially	  expressed	  (DE)	  between	  M1	  and	  M2a	  macrophages,	  several	  independently	  generated	  datasets	  were	  used,	  originating	  from	  different	  laboratories	  and	  analyzed	  separately.	  The	  datasets	  included	  were	  RNA-­‐seq	  results	  from	  four	  donors	  generated	  by	  our	  lab,	  the	  dataset	  publicly	  available	  as	  GSE57614	  [33],	  and	  the	  dataset	  publicly	  available	  as	  GSE36537	  [34].	  	  In	  the	  RNA-­‐seq	  dataset,	  monocytes	  from	  four	  donors	  were	  polarized	  to	  four	  different	  macrophage	  phenotypes	  (Figure	  1).	  	  The	  two	  discussed	  here	  are	  M1	  and	  M2	  macrophages,	  polarized	  using	  the	  cytokine	  interferon-­‐gamma	  (IFNg)	  and	  lipopolysaccharide	  (LPS)	  for	  M1	  and	  interleukin-­‐4	  (IL4)	  and	  interleukin-­‐13	  (IL13)	  for	  M2	  cells.	  Monocytes	  were	  first	  differentiated	  into	  macrophages	  through	  the	  application	  of	  macrophage	  colony	  stimulating	  factor	  (MCSF)	  at	  days	  0,	  3,	  and	  5.	  	  The	  cytokines	  mentioned	  above	  were	  added	  at	  day	  5,	  and	  the	  macrophages	  were	  left	  in	  the	  cytokine	  containing	  media	  for	  48	  hours,	  before	  being	  harvested	  at	  day	  7.	  	  	  
	  
Figure	  1.	  Macrophage	  polarization	  protocol	  
over	  a	  seven	  day	  time	  period.	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After	  harvesting,	  RNA	  was	  extracted	  from	  the	  cells	  and	  used	  for	  RNA-­‐seq.	  	  Differential	  expression	  was	  determined	  using	  the	  voom-­‐limma	  R	  package	  [35].	  	  Thresholds	  for	  false	  discovery	  rate	  adjusted	  p-­‐value	  and	  log	  base	  10	  fold-­‐change	  (logFC)	  were	  established	  before	  the	  analysis	  as	  0.05	  and	  2,	  respectively.	  	  The	  two	  other	  datasets	  used	  in	  this	  analysis	  summarized	  their	  polarization	  methods	  in	  their	  publications	  [33,	  34].	  	  From	  the	  publicly	  available	  data,	  which	  originated	  from	  microarray	  experiments,	  the	  limma	  R	  package	  [36]	  was	  used	  to	  identify	  DE	  genes	  with	  the	  same	  thresholds.	  	  	  
After	  identifying	  consistently	  significantly	  DE	  genes	  between	  phenotypes,	  those	  genes	  were	  assessed	  for	  expression	  in	  additional	  wound	  cell	  types,	  using	  a	  variety	  of	  sources.	  	  This	  was	  conducted	  manually	  via	  searching	  available	  data,	  due	  to	  the	  manageable	  number	  of	  genes	  remaining.	  	  Sources	  used	  included	  the	  Human	  Protein	  Atlas,	  GeneCards,	  NCBI,	  and	  published	  literature.	  	  	  
This	  process	  resulted	  in	  eight	  M1	  markers	  and	  eight	  M2	  markers,	  but	  this	  only	  considered	  baseline	  cell	  responses.	  	  In	  order	  to	  assess	  whether	  these	  markers	  change	  their	  expression	  following	  activation	  due	  to	  an	  immune	  response,	  publicly	  available	  datasets	  were	  used	  to	  look	  for	  DE	  in	  these	  genes	  between	  baseline	  and	  activated	  cell	  types,	  focusing	  on	  keratinocytes	  (GSE30355)	  [37],	  fibroblasts	  (GSE7890)	  [38],	  neutrophils	  (GSE50790)	  [39],	  endothelial	  cells	  (GSE38396)	  [40],	  and	  T-­‐cells	  (GSE39596)	  [41].	  	  If	  a	  fold	  change	  greater	  than	  one	  occurred	  between	  the	  activated	  and	  baseline	  cell	  types,	  that	  gene	  was	  eliminated.	  	  This	  resulted	  in	  six	  M1	  markers	  and	  seven	  M2	  markers.	  These	  remaining	  genes	  were	  verified	  as	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Additionally,	  thresholds	  were	  determined	  before	  the	  analysis	  at	  each	  stage	  of	  the	  process	  shown	  in	  Figure	  2.	  	  These	  thresholds,	  seen	  in	  Figure	  3,	  could	  potentially	  be	  varied	  in	  future	  work,	  but	  currently	  determine	  which	  genes	  are	  used	  as	  input	  for	  the	  models	  discussed	  in	  Aim	  2.	  
Figure	  2.	  Flow	  chart	  of	  gene	  set	  determination	  process.	  	  The	  descriptions	  on	  the	  left	  
describe	  the	  criteria	  for	  inclusion	  in	  each	  group.	  
Figure	  3.	  Thresholds	  used	  at	  each	  stage	  to	  
determine	  which	  genes	  to	  include	  in	  the	  model	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4.3	  Results	  
The	  genes	  that	  met	  the	  inclusion	  criteria	  as	  described	  above	  are	  shown	  in	  table	  2,	  with	  a	  brief	  description	  summarized	  from	  NCBI	  GeneCards	  [43].	  
Table	  2.	  Macrophage	  specific	  genes	  differentially	  expressed	  between	  the	  phenotypes	  
M1	  gene	   Function	  XAF1	   Involved	  in	  apoptosis	  signaling	  pathway.	  APOL1	   Involved	  in	  lipid	  exchange	  and	  transport.	  NOD2	   Plays	  a	  role	  in	  response	  to	  LPS.	  ASPHD2	   Encodes	  a	  protein	  involved	  in	  dioxygenase	  activity.	  CLEC4D	   Involved	  in	  cell-­‐cell	  signaling	  and	  adhesion.	  CCL19	   Involved	  in	  lymphocyte	  circulation	  and	  binds	  to	  CCR7.	  	  
M2	  gene	   Function	  ALOX15	   Involved	  in	  apoptotic	  pathways	  and	  iron	  ion	  binding.	  CCL26	   Produces	  cytokines	  involved	  in	  immunoregulatory	  processes.	  CLEC4G	   Involved	  in	  immune	  response	  and	  carbohydrate	  binding.	  CTNNAL1	   Involved	  in	  structural	  molecule	  activity	  and	  cadherin	  binding.	  PLCB1	   Plays	  a	  role	  in	  intracellular	  transduction	  of	  extracellular	  signals.	  RAMP1	   Involved	  in	  receptor	  activity,	  specifically	  the	  calcitonin	  receptor.	  WNT5B	   Encodes	  for	  signaling	  proteins,	  involved	  in	  development	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The	  differential	  expression	  of	  these	  markers	  was	  verified	  in	  a	  fourth	  independent	  dataset.	  These	  results	  show	  that	  the	  M1	  genes	  are	  significantly	  up	  regulated	  in	  these	  additional	  M1	  samples,	  and	  the	  same	  is	  true	  for	  the	  M2	  genes	  in	  these	  additional	  M2	  samples	  (Figure	  4).	  	  The	  enrichment	  of	  each	  signature	  in	  the	  fourth	  dataset	  between	  M1	  and	  M2	  polarized	  macrophage	  samples	  was	  shown	  using	  the	  QuSAGE	  R	  package	  [44].	  The	  QuSAGE	  algorithm	  accounts	  for	  the	  correlation	  of	  expression	  between	  genes	  through	  the	  calculation	  of	  a	  variance	  inflation	  factor	  that	  represents	  the	  degree	  of	  correlation	  between	  genes.	  It	  generates	  a	  probability	  density	  function	  for	  each	  gene	  set.	  The	  dotted	  line	  in	  Figure	  4	  represents	  no	  difference	  in	  expression	  of	  the	  signature	  genes	  between	  M1	  and	  M2	  samples.	  	  The	  red	  curve	  represents	  M1	  genes,	  and	  since	  it	  is	  to	  the	  right	  of	  the	  curve,	  it	  indicates	  that	  those	  genes	  are	  up	  regulated	  in	  M1	  samples	  as	  compared	  to	  M2	  samples.	  	  The	  blue	  curve	  represents	  M2	  genes,	  and	  shows	  down-­‐regulation	  in	  M1	  samples	  as	  compared	  to	  M2	  samples,	  and	  up-­‐regulation	  in	  M2	  samples	  over	  M1	  samples.	  
	  
Figure	  4.	  Activation	  of	  M1	  and	  M2	  genes	  in	  additional	  dataset.	  	  The	  x-­‐axis	  shows	  the	  activation	  of	  the	  gene	  sets	  
in	  M1	  samples	  (left)	  as	  compared	  to	  M2	  samples,	  and	  the	  activation	  of	  the	  gene	  sets	  in	  M2	  samples	  (right)	  as	  
compared	  to	  M1	  samples.	  	  If	  expression	  were	  equal	  in	  both	  samples,	  the	  curve	  would	  fall	  on	  the	  dotted	  line.	  	  
Each	  curve	  is	  a	  probability	  density	  function	  representing	  the	  activation	  of	  the	  entire	  set,	  and	  the	  density	  is	  on	  
the	  y-­‐axis.	  	  Red	  indicates	  M1	  genes	  and	  blue	  indicates	  M2	  genes.	  ****	  <	  1e-­‐4	  and	  *****	  <	  1e-­‐5,	  student’s	  t-­‐test	  
with	  null	  hypothesis	  that	  the	  activation	  is	  equal	  to	  0.	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4.4	  Discussion	  The	  genes	  identified	  here	  as	  consistently	  differentially	  expressed	  between	  phenotypes	  indicate	  that	  their	  functions	  may	  play	  a	  role	  in	  differentiating	  the	  behavior	  between	  the	  two	  main	  macrophage	  phenotypes.	  	  Additionally,	  the	  downstream	  effect	  of	  the	  higher	  expression	  of	  these	  genes	  in	  the	  relative	  phenotypes	  may	  play	  a	  role	  in	  wound	  healing,	  since	  M1	  macrophages	  have	  been	  found	  to	  persist	  in	  chronic	  wounds.	  	  Using	  three	  independently	  created	  datasets	  to	  identify	  these	  markers	  for	  each	  phenotype	  results	  in	  a	  high	  confidence	  list,	  as	  these	  genes	  appeared	  significantly	  differentially	  expressed	  between	  M1	  and	  M2	  macrophages	  polarized	  using	  slightly	  varying	  protocols	  in	  different	  laboratories,	  and	  their	  gene	  expression	  was	  assessed	  using	  different	  platforms.	  	  The	  behavior	  of	  these	  genes	  then	  persisted	  when	  verified	  in	  a	  fourth	  dataset	  containing	  data	  from	  M1	  and	  M2	  in	  vitro	  polarized	  macrophages	  not	  used	  in	  forming	  the	  list	  of	  potential	  markers.	  	  	  
The	  functional	  effects	  of	  these	  genes,	  as	  summarized	  in	  table	  2,	  indicate	  that	  they	  are	  involved	  in	  defining	  the	  behaviors	  associated	  with	  M1	  and	  M2	  macrophages.	  Regardless	  of	  the	  success	  of	  incorporating	  these	  genes	  into	  a	  predictive	  model,	  this	  aim	  has	  resulted	  in	  high	  confidence	  markers	  for	  both	  the	  pro-­‐	  and	  anti-­‐	  inflammatory	  macrophage	  phenotypes,	  and	  these	  genes	  have	  been	  assessed	  so	  to	  ensure	  they	  do	  not	  also	  exhibit	  differential	  expression	  in	  other	  immune	  cells	  when	  those	  cells	  are	  responding	  to	  an	  external	  stimulus.	  	  This	  aim	  makes	  use	  of	  publicly	  available	  data	  to	  increase	  efficiency	  in	  resource	  usage,	  and	  also	  provides	  insight	  into	  the	  perceived	  lack	  of	  consistency	  between	  experiments,	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according	  to	  this	  analysis.	  	  Different	  numbers	  of	  genes	  meeting	  the	  established	  DE	  criteria	  were	  found	  from	  each	  dataset,	  and	  then	  a	  small	  percentage	  of	  those	  genes	  were	  found	  to	  be	  consistently	  significantly	  DE	  across	  the	  datasets,	  indicating	  a	  lack	  of	  overlap	  between	  different	  experimental	  studies,	  potentially	  due	  to	  variations	  in	  polarization	  protocol	  or	  lab	  environment.	  	  This	  again	  lends	  credence	  to	  the	  confidence	  in	  the	  markers	  established	  here,	  but	  also	  demonstrates	  the	  importance	  of	  incorporating	  this	  kind	  of	  meta-­‐analysis	  of	  multiple	  sources	  when	  identifying	  markers.	  
5.	  Aim	  2:	  Design	  a	  predictive	  model.	  
5.1	  Experimental	  Design	  
Three	  training	  data	  sets	  were	  created	  consisting	  of	  samples	  with	  varying	  proportions	  of	  M1	  and	  M2	  cells.	  Expression	  of	  the	  established	  markers	  for	  each	  phenotype	  discovered	  in	  Aim	  1	  was	  assessed	  and	  correlated	  with	  the	  known	  fraction	  of	  M1	  cells	  in	  the	  sample,	  termed	  sample	  composition.	  	  Three	  donors	  were	  used	  to	  generate	  these	  samples,	  in	  datasets	  processed	  in	  three	  separate	  batches,	  one	  for	  each	  donor	  set.	  Thresholds	  were	  established	  for	  expression	  correlation	  with	  sample	  composition	  based	  on	  this	  data,	  and	  a	  correlation	  threshold	  of	  r	  =	  0.4	  was	  used	  as	  a	  cutoff	  for	  moderate	  correlation	  [45].	  A	  variety	  of	  models	  were	  used	  with	  varying	  genes	  as	  input,	  summarized	  in	  table	  3.	  A	  fourth	  dataset,	  consisting	  of	  M1	  and	  M2	  macrophages	  generated	  from	  a	  fourth	  donor	  as	  well	  as	  additional	  fibroblasts	  and	  endothelial	  cells,	  was	  created	  to	  test	  the	  best-­‐performing	  models	  built	  using	  data	  from	  the	  first	  three	  datasets.	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Table	  3.	  Potential	  models	  to	  predict	  sample	  composition	  based	  on	  gene	  expression	  
Model	   Description	  Linear	  Regression	   Outputs	  the	  best-­‐fitting	  straight	  line	  for	  a	  plot	  of	  predictors	  vs.	  outcome	  through	  minimizing	  the	  distance	  of	  each	  point	  from	  the	  line	  Logistic	  Regression	   Predicts	  the	  probability	  of	  a	  sample	  belonging	  to	  a	  certain	  category	  based	  on	  the	  input	  data	  through	  a	  logistic	  fit	  Neural	  Network	   Series	  of	  layers	  with	  varying	  numbers	  of	  nodes	  that	  assign	  weights	  to	  the	  input	  features,	  or	  the	  combination	  of	  those	  features,	  to	  generate	  a	  prediction	  Support	  Vector	  Machine	   Uses	  a	  subset	  of	  the	  training	  points	  most	  important	  in	  differentiating	  the	  data	  (termed	  support	  vectors)	  and	  transforms	  the	  data	  using	  a	  specified	  kernel	  equation	  and	  then	  finds	  a	  function	  that	  minimizes	  prediction	  error	  	  
	   For	  the	  methods	  in	  table	  3,	  different	  types	  of	  input	  were	  used.	  	  For	  all	  models,	  all	  genes	  were	  inputted	  as	  individual	  data	  points,	  and	  then	  for	  linear	  and	  logistic	  regression,	  a	  single	  variable	  model	  was	  implemented	  using	  the	  M1/M2	  score	  of	  a	  sample.	  The	  score	  is	  the	  sum	  of	  M1	  marker	  expression	  divided	  by	  the	  sum	  of	  M2	  marker	  expression,	  and	  this	  measure	  has	  been	  used	  previously	  with	  less	  specific	  macrophage	  markers	  to	  assess	  the	  dominant	  phenotype	  in	  a	  sample	  [8].	  	  	  
	   Additionally,	  linear	  and	  logistic	  fits	  were	  generated	  using	  data	  from	  the	  gene	  most	  highly	  correlated	  with	  sample	  composition,	  and	  the	  top	  two	  most	  correlated	  genes	  (one	  for	  each	  phenotype),	  to	  see	  if	  the	  model	  could	  achieve	  desired	  performance	  using	  only	  one	  or	  two	  input	  genes.	  	  The	  M1/M2	  score	  was	  also	  calculated	  using	  just	  those	  two	  genes	  and	  used	  as	  input.	  	  The	  flow	  of	  model	  development	  is	  listed	  below:	  
1. Test	  models	  built	  using	  data	  from	  one	  donor	  on	  remaining	  two	  donors	  to	  assess	  usefulness	  as	  in	  vitro	  assay	  when	  a	  standard	  curve	  is	  possible	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2. Test	  models	  built	  using	  data	  from	  two	  donors	  on	  remaining	  donor	  3. Test	  models	  built	  using	  data	  from	  three	  donors	  on	  remaining	  donor	  with	  additional	  cell	  types	  included	  to	  assess	  usefulness	  in	  assessing	  clinical	  wound	  samples	  4. Apply	  feature	  selection	  to	  best-­‐performing	  models	  from	  step	  #3	  
5.2	  Methods	  
Phenotypically	  heterogeneous	  macrophage	  samples	  were	  generated	  in	  vitro	  to	  serve	  as	  training	  data	  to	  fit	  a	  predictive	  model	  to	  the	  gene	  expression	  values	  that	  would	  output	  the	  relative	  composition	  of	  the	  sample.	  Primary	  human	  monocytes	  were	  polarized	  to	  macrophages	  following	  a	  7-­‐day	  protocol,	  seen	  in	  Figure	  1	  and	  as	  described	  in	  Aim	  1.	  	  On	  day	  7	  of	  the	  culture,	  the	  cells	  were	  lysed,	  combined	  in	  differing	  combinations	  of	  M1	  and	  M2	  cells,	  and	  stored	  at	  -­‐80	  °C	  until	  further	  processing.	  
Samples	  were	  creating	  with	  different	  proportions	  of	  M1	  and	  M2	  cells,	  ranging	  from	  samples	  that	  contained	  100%	  M1	  cells	  and	  0%	  M2	  cells	  to	  100%	  M2	  cells	  and	  0%	  M1	  cells.	  	  This	  composition	  was	  represented	  as	  a	  percentage	  of	  M1	  cells,	  so	  a	  sample	  with	  composition	  output	  of	  1	  was	  100%	  M1	  and	  0%	  M2,	  while	  an	  output	  of	  0.25	  indicates	  25%	  M1	  and	  75%	  M2.	  	  RNA	  extraction	  was	  done	  using	  an	  RNAqueous®-­‐Micro	  kit	  (Life	  Technologies)	  according	  to	  the	  manufacturer's	  instructions.	  The	  RNA	  quantity	  was	  measured	  on	  a	  Nanodrop	  ND1000	  and	  for	  quality	  control,	  the	  260/280	  absorbance	  ratio	  must	  be	  above	  2.	  The	  samples	  were	  stored	  at	  −80	  °C	  until	  cDNA	  synthesis.	  The	  DNase	  I	  amplification	  grade	  kit	  (Life	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Technologies)	  was	  applied	  to	  the	  samples,	  according	  to	  the	  manufacturer's	  instructions.	  Reverse	  transcription	  leading	  to	  cDNA	  synthesis	  was	  then	  performed	  using	  the	  High	  Capacity	  kit	  (Life	  Technologies),	  according	  to	  the	  manufacturer's	  instructions.	  Quantitative	  RT-­‐PCR	  analysis	  was	  then	  performed	  with	  20	  ng	  cDNA	  per	  each	  reaction	  and	  the	  Fast	  SYBR®	  Green	  PCR	  Master	  Mix	  (Life	  Technologies).	  The	  expression	  of	  each	  gene	  was	  normalized	  to	  the	  expression	  of	  the	  housekeeping	  gene	  GAPDH	  (2−ΔCt)	  and	  log-­‐normalized,	  and	  any	  samples	  with	  GAPDH	  values	  significantly	  different	  from	  the	  mean	  were	  removed.	  	  A	  melt	  curve	  analysis	  was	  used	  to	  assess	  the	  stability	  of	  the	  primers,	  and	  any	  dimerized	  primers	  were	  removed	  from	  analysis.	  All	  primers,	  listed	  in	  table	  4,	  were	  synthesized	  by	  Life	  Technologies.	  	  Primers	  were	  chosen	  based	  on	  GC	  content	  (50-­‐60%),	  annealing	  temperature	  (55-­‐65	  degrees	  Celsius),	  length	  (18-­‐22	  bp),	  self-­‐complementarity	  (<	  4),	  and	  dimers	  (<	  3).	  	  
Table	  4.	  Primers	  used	  for	  assessing	  gene	  expression	  
Gene	   Forward	   Reverse	  APOL1	   TTACCAACTCACACGAGGCATT	   CTCCACCTGTTCACCGCTTT	  NOD2	   CACCGTCTGGAATAAGGGTACT	   TTCATACTGGCTGACGAAACC	  ASPHD2	   CCGAGGACTGATTGTCTGACC	   CAGTACCACACGAAGAGGACC	  CLEC4D	   CTGATACCTTCGGTTATTGCTGT	   GCACTCCTGTGCCTCTCTTAC	  CCL19	   CCAGCCTCACATCACTCACACCTTGC	   TGTGGTGAACACTACAGCAGGCACCC	  XAF1	   GAGCATGCAGAAGTCCTCGCT	   CCTGTTCACTGCGACAGACATCT	  ALOX15	   GGGCAAGGAGACAGAACTCAA	   CAGCGGTAACAAGGGAACCT	  CTNNAL1	   GGGACTGGAGATCAAAACTCG	   GTCCTACACGCTGAATTGCTT	  RAMP1	   GAGACGCTGTGGGTGACTG	   TCGGCTACTCTGGACTCCTG	  CCL26	   CTGGACCTGGGTGCGAAGC	   TGGATGGGTACAGACTTTCTTGCC	  PLCB1	   AGCTCTCAGAACAAGCCTCCAACA	   ATCATCGTCGTCGTCACTTTCCGT	  WNT5B	   AGATCGTGGACCAGTACATCTG	   TTACGGAACCCATCTACATTCTG	  CLEC4G	   GCCATGGACACCACCAGGTACAGC	   GACTCAGCAGTTGTGCCTTTTCTC	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This	  process	  was	  repeated	  in	  three	  separate	  batches	  with	  three	  different	  donors.	  The	  gene	  expression	  then	  served	  as	  input	  to	  the	  predictive	  models	  described	  in	  the	  previous	  section.	  The	  fourth	  dataset	  was	  created	  using	  M1	  and	  M2	  macrophages	  polarized	  following	  the	  same	  method	  seen	  in	  Figure	  1,	  but	  also	  including	  endothelial	  cells	  (Lonza,	  EGM-­‐2)	  and	  fibroblasts	  (Lonza,	  FGM-­‐2).	  	  These	  were	  cultured	  in	  their	  respective	  growth	  medias	  using	  the	  EGM-­‐2	  BulletKit	  with	  growth	  factors	  (Lonza)	  and	  the	  FGM-­‐2	  BulletKit	  with	  growth	  factors	  (Lonza),	  according	  to	  the	  manufacturer’s	  instructions,	  for	  two	  days,	  before	  being	  detached	  via	  Trypsin/EDTA	  (Lonza),	  according	  to	  the	  manufacturer’s	  instructions,	  lysed,	  and	  added	  to	  the	  samples	  that	  varied	  in	  M1/M2	  composition.	  	  Fibroblasts	  and	  endothelial	  cells	  respectively	  accounted	  for	  12.5%	  volume	  of	  the	  sample,	  and	  so	  25%	  of	  the	  total	  sample	  volume	  consisted	  of	  non-­‐macrophage	  cells,	  and	  the	  remaining	  75%	  of	  the	  sample	  contained	  varying	  proportions	  of	  M1	  and	  M2	  macrophages.	  
After	  assessing	  gene	  expression	  in	  the	  samples,	  each	  gene’s	  expression	  was	  correlated	  with	  known	  sample	  composition	  (represented	  as	  the	  fraction	  of	  M1	  cells	  in	  the	  sample)	  using	  the	  Pearson	  product-­‐moment	  correlation	  coefficient.	  	  A	  variety	  of	  models	  were	  fitted	  to	  the	  data	  to	  determine	  the	  best	  method	  for	  predicting	  sample	  composition.	  	  Linear	  and	  logistic	  regression	  were	  implemented	  using	  the	  glm	  package	  in	  R.	  	  The	  NN	  and	  SVM	  methods	  were	  implemented	  in	  MATLAB.	  	  Functions	  from	  MATLAB’s	  Neural	  Net	  toolbox	  and	  the	  Statistics	  and	  Machine	  Learning	  toolbox	  were	  used	  both	  to	  train	  and	  test	  the	  models,	  as	  well	  as	  to	  implement	  feature	  selection.	  	  The	  neural	  net,	  Figure	  5,	  was	  constructed	  with	  15	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hidden	  layers	  and	  trained	  on	  70%	  of	  the	  data,	  validated	  on	  15%	  and	  then	  tested	  on	  the	  remaining	  15%,	  using	  the	  fitnet	  and	  train	  functions	  to	  implement	  the	  network.	  	  The	  support	  vector	  machine	  was	  created	  using	  the	  fitrsvm	  function,	  with	  a	  linear	  kernel.	  The	  model	  used	  70	  samples	  of	  a	  total	  87	  training	  samples	  as	  the	  support	  vectors.	  	  The	  resulting	  weights	  for	  the	  neural	  net	  are	  shown	  in	  the	  appendix.	  
In	  order	  to	  assess	  the	  accuracy	  of	  each	  method,	  that	  model’s	  predictions	  were	  correlated	  with	  known	  sample	  composition	  to	  produce	  a	  correlation	  coefficient	  measure	  (r	  in	  Results	  section),	  and	  the	  average	  error	  (Avg.	  Error	  in	  Results	  section)	  for	  those	  predictions	  was	  calculated	  by	  summing	  the	  difference	  between	  each	  prediction	  and	  known	  value,	  and	  dividing	  by	  the	  number	  of	  test	  samples,	  using	  leave-­‐one-­‐out-­‐cross-­‐validation	  to	  build	  the	  model	  using	  all	  but	  one	  sample	  and	  test	  on	  that	  remaining	  sample	  when	  assessing	  model	  performance	  on	  training	  data.	  
5.3	  Results	  
5.3.1	  Models	  trained	  using	  data	  from	  one	  donor	  
Gene	  expression	  trends	  and	  correlation	  with	  sample	  composition	  from	  results	  generated	  from	  the	  first	  dataset	  were	  assessed	  to	  infer	  which	  genes	  were	  most	  predictive	  of	  composition.	  	  Those	  correlations	  are	  summarized	  in	  table	  5.	  	  One	  
Figure	  5.	  Neural	  network	  construction	  including	  input,	  hidden	  layers,	  and	  
output	  
25	  
gene,	  CTNNAL1,	  failed	  the	  primer	  quality	  control	  check	  due	  to	  dimerization,	  and	  so	  that	  data	  is	  not	  included	  in	  future	  discussions.	  	  
Table	  5.	  Pearson	  product-­‐moment	  correlation	  coefficient	  for	  each	  gene	  with	  sample	  composition,	  
defined	  as	  fraction	  of	  sample	  containing	  M1	  cells.	  
Gene	   Correlation	  	  ASPHD2	   0.5952	  APOL1	   0.3559	  CLEC4D	   0.02412	  CCL19	   0.4749	  XAF1	   0.7646	  NOD2	   0.1068	  CCL26	   -­‐0.8376	  CLEC4G	   -­‐0.7202	  ALOX15	   -­‐0.8118	  PLCB1	   -­‐0.7945	  RAMP1	   -­‐0.8585	  WNT5B	   -­‐0.4429	  	  
















Figure	  6.	  Expression	  for	  each	  gene	  across	  samples	  with	  varying	  
fractions	  of	  M1	  cells.	  	  Dark	  blue	  indicates	  low	  expression	  while	  
brighter	  yellow	  shows	  higher	  expression.	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Models	  were	  developed	  from	  the	  first	  donor	  and	  tested	  using	  data	  from	  that	  donor.	  	  Both	  multiple	  linear	  and	  multiple	  logistic	  regression	  equations	  were	  fitted	  using	  all	  genes.	  	  Those	  same	  fits	  were	  generated	  using	  only	  one	  gene,	  CCL26,	  which	  was	  most	  highly	  correlated	  with	  sample	  composition	  across	  donors.	  	  A	  two	  input	  model	  was	  created,	  using	  the	  most	  consistently	  highly	  correlated	  genes	  for	  each	  phenotype	  across	  donors,	  CCL26	  and	  XAF1.	  	  	  A	  single	  linear	  and	  logistic	  regression	  model	  was	  used	  with	  the	  M1/M2	  score	  as	  the	  sole	  input.	  	  Finally,	  all	  data	  was	  inputted	  as	  training	  data	  to	  a	  support	  vector	  machine	  framework,	  and	  a	  neural	  network.	  	  Model	  accuracy	  is	  summarized	  in	  table	  6,	  with	  the	  models	  in	  italics	  meeting	  the	  established	  criteria.	  
Table	  6.	  Average	  error	  (column	  2)	  and	  correlation	  with	  known	  values	  (column	  3)	  for	  each	  model	  
implemented	  using	  training	  and	  test	  data	  from	  the	  same	  donor.	  	  	  
Model	  (Donor	  1)	   Avg.	  Error	  (%)	   r	   R2	  Ccl26	  Lin.	  Reg.	   20.2	   0.830	   0.689	  Ccl26	  Log.	  Reg.	   17.9	   0.861	   0.741	  Ccl26+Xaf1	  Lin.	  Reg.	   15.1	   0.913	   0.833	  
Ccl26+Xaf1	  Log.	  Reg.	   14.6	   0.922	   0.850	  Xaf1/Ccl26	  Lin.	  Reg.	   15.7	   0.913	   0.834	  Xaf1/Ccl26	  Log.	  Reg.	   15.3	   0.916	   0.839	  All	  Genes	  Lin.	  Reg.	   15.7	   0.972	   0.945	  All	  Genes	  Log.	  Reg.	   20.7	   0.982	   0.964	  
Score	  Lin.	  Reg.	   13.9	   0.927	   0.859	  
Score	  Log.	  Reg.	   10.5	   0.956	   0.914	  
All	  Genes	  SVM	   2.97	   0.994	   0.988	  
All	  Genes	  NN	   0.578	   0.999	   0.998	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Next,	  those	  models	  meeting	  the	  criteria	  established	  previously,	  average	  error	  less	  than	  15%	  and	  a	  correlation	  with	  known	  composition	  greater	  than	  0.9,	  were	  tested	  on	  the	  remaining	  two	  donors,	  with	  the	  results	  summarized	  in	  table	  7	  below.	  
Table	  7.	  Performance	  of	  model	  trained	  on	  one	  donor	  on	  the	  remaining	  two	  donors.	  	  Error	  2	  and	  error	  3	  
are	  the	  average	  errors	  from	  the	  model	  predictions	  for	  donors	  2	  and	  3,	  respectively	  
	  
5.3.2	  Models	  trained	  using	  data	  from	  two	  donors	  
In	  order	  to	  potentially	  increase	  accuracy	  and	  account	  for	  donor-­‐to-­‐donor	  variation,	  the	  process	  was	  repeated,	  with	  the	  input	  to	  model	  formation	  now	  containing	  data	  from	  two	  separate	  donors	  and	  tested	  on	  the	  remaining	  third	  donor.	  	  This	  was	  done	  using	  all	  possible	  combinations	  of	  two	  donors	  from	  the	  three	  datasets,	  which	  resulted	  in	  three	  models	  built	  on	  data	  from	  two	  donors	  and	  tested	  on	  data	  from	  a	  third	  donor,	  and	  the	  average	  and	  standard	  deviation	  of	  both	  the	  average	  error	  and	  correlation	  with	  known	  sample	  composition	  for	  the	  three	  models	  using	  leave-­‐one-­‐out	  cross	  validation	  is	  shown	  in	  table	  8.	  	  	  Testing	  results	  for	  models	  meeting	  criteria	  (italics	  in	  table	  8)	  are	  shown	  in	  table	  9.	  
	  
	  
Model	  	   Error	  2	  (%)	   r	  	   R2	   Error	  3	  (%)	   r	   R2	  Ccl26+Xaf1	  Log.	  Reg.	   169	   0.821	   0.674	   104	   0.761	   0.579	  Score	  Lin.	  Reg.	   30.1	   0.687	   0.472	   29.2	   0.206	   0.042	  Score	  Log.	  Reg.	   358	   0.688	   0.473	   118	   0.206	   0.042	  All	  Genes	  SVM	   22.6	   0.342	   0.117	   22.2	   0.757	   0.573	  All	  Genes	  NN	   38.8	   0.071	   0.005	   37.5	   0.194	   0.038	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Table	  8.	  Average	  error	  and	  correlation	  of	  model	  predictions	  vs.	  known	  composition	  across	  three	  
different	  models	  for	  each	  category.	  	  SD	  is	  standard	  deviation.	  
Model	   Avg.	  Error	  (%)	   SD	   r	   SD	   R2	  Ccl26	  Lin.	  Reg.	   23.3	   2.35	   0.671	   0.10	   0.450241	  Ccl26	  Log.	  Reg.	   21.8	   3.83	   0.712	   0.12	   0.506944	  Ccl26+Xaf1	  Lin.	  Reg.	   17.7	   1.53	   0.838	   0.04	   0.702244	  Ccl26+Xaf1	  Log.	  Reg.	   15.9	   1.92	   0.882	   0.02	   0.777924	  All	  Genes	  Lin.	  Reg.	   16.0	   1.14	   0.906	   0.02	   0.820836	  
All	  Genes	  Log.	  Reg.	   14.0	   0.32	   0.930	   0.01	   0.8649	  Score	  Lin.	  Reg.	   25.8	   5.15	   0.581	   0.19	   0.337561	  Score	  Log.	  Reg.	   24.0	   4.26	   0.618	   0.20	   0.381924	  Xaf1/Ccl26	  Lin.	  Reg.	   20.9	   4.84	   0.817	   0.06	   0.667489	  Xaf1/Ccl26	  Log.	  Reg.	   22.2	   11.02	   0.876	   0.01	   0.767376	  
All	  Genes	  SVM	   6.46	   0.999	   0.959	   0.01	   0.919681	  
All	  Genes	  NN	   4.11	   1.72	   0.979	   0.02	   0.958441	  
	  




Model	   Avg.	  Error	  (%)	   SD	   r	   SD	   R2	  All	  Genes	  Log.	  Reg.	   168.64	   80.64	   0.870	   0.04	   0.757	  All	  Genes	  SVM	   18.83	   1.80	   0.756	   0.09	   0.572	  All	  Genes	  NN	   16.30	   3.91	   0.794	   0.11	   0.630436	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5.3.3	  Models	  trained	  using	  data	  from	  three	  donors	  
Finally,	  all	  donors	  were	  incorporated	  into	  the	  model	  generation	  and	  then	  tested	  on	  the	  fourth	  dataset,	  as	  described	  above.	  	  The	  above	  models	  were	  also	  tested	  for	  their	  predictive	  ability	  based	  on	  the	  known	  compositions	  for	  this	  fourth	  test	  dataset.	  	  The	  accuracy	  and	  fit	  of	  these	  models	  are	  summarized	  in	  tables	  10	  and	  11.	  
Table	  10.	  Performance	  of	  models	  trained	  using	  data	  from	  three	  donors	  	  
Model	  	   Avg.	  Error	  (%)	   r	   R2	  Ccl26	  Lin.	  Reg.	   23.4	   0.669	   0.448	  Ccl26	  Log.	  Reg.	   22.4	   0.704	   0.496	  Ccl26+Xaf1	  Lin.	  Reg.	   17.6	   0.835	   0.697	  Ccl26+Xaf1	  Log.	  Reg.	   15.1	   0.883	   0.780	  Xaf1/Ccl26	  Lin.	  Reg.	   19.7	   0.812	   0.659	  Xaf1/Ccl26	  Log.	  Reg.	   15.7	   0.875	   0.766	  All	  Genes	  Lin.	  Reg.	   15.6	   0.895	   0.801	  
All	  Genes	  Log.	  Reg.	   13.4	   0.924	   0.854	  Score	  Lin.	  Reg.	   26.5	   0.562	   0.316	  Score	  Log.	  Reg.	   25.5	   0.591	   0.349	  
All	  Genes	  SVM	   2.13	   0.956	   0.914	  
All	  Genes	  NN	   1.86	   0.970	   0.941	  	  
Table	  11.	  Models	  trained	  using	  data	  from	  three	  donors	  performance	  on	  predicting	  composition	  of	  fourth	  
dataset,	  including	  additional	  cell	  types	  
Model123	   Avg.	  Error	  (%)	   r	   R2	  All	  Genes	  SVM	   17.1	   0.893	   0.798	  All	  Genes	  NN	   21.2	   0.742	   0.551	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After	  determining	  the	  best	  models	  to	  proceed	  with	  predicting	  composition,	  feature	  selection	  was	  applied	  to	  computationally	  determine	  the	  best	  genes	  to	  include	  in	  the	  model.	  	  Stepwise	  backward	  feature	  selection	  was	  used	  to	  incorporate	  any	  interactions	  between	  features,	  and	  so	  the	  model	  was	  first	  built	  using	  all	  genes,	  and	  then	  the	  lowest	  contributing	  feature	  was	  removed	  in	  each	  step.	  	  This	  was	  done	  on	  models	  built	  using	  all	  three	  donors,	  and	  then	  tested	  on	  the	  fourth	  donor	  that	  included	  contaminating	  cell	  types,	  as	  the	  overall	  goal	  is	  to	  garner	  predictions	  in	  the	  presence	  of	  additional	  cell	  types	  when	  a	  standard	  curve	  cannot	  be	  generated.	  	  If	  a	  standard	  curve	  is	  available,	  as	  during	  in	  vitro	  experiments,	  the	  previous	  models	  can	  be	  used	  to	  build	  the	  model	  on	  the	  same	  donor	  as	  the	  unknown	  samples,	  which	  is	  highly	  accurate	  (table	  6).	  	  This	  process	  was	  done	  for	  neural	  net	  and	  support	  vector	  machine	  models,	  as	  they	  showed	  the	  best	  accuracy	  in	  prediction	  when	  built	  using	  all	  genes	  and	  their	  expression	  values	  from	  three	  donors	  when	  tested	  on	  a	  fourth	  dataset	  containing	  additional	  cell	  types,	  and	  so	  it	  is	  those	  models	  we	  seek	  to	  optimize.	  	  For	  both	  the	  neural	  net	  and	  support	  vector	  machine,	  50	  independent	  models	  were	  generated	  using	  the	  same	  training	  data	  from	  three	  donors.	  	  This	  was	  done	  due	  to	  variations	  in	  initial	  conditions.	  	  Neural	  nets	  start	  with	  randomly	  initiated	  weights	  for	  each	  node,	  and	  so	  those	  initial	  conditions	  can	  create	  variations	  in	  the	  results.	  Results	  from	  the	  SVM	  did	  not	  change	  from	  run	  to	  run.	  	  The	  average	  error	  in	  prediction	  for	  the	  fourth	  donor	  containing	  additional	  cell	  types	  was	  used	  as	  the	  minimizing	  factor.	  	  So,	  the	  models	  are	  first	  trained	  using	  data	  from	  all	  9	  features	  (genes),	  and	  then	  the	  lowest	  ranked	  gene	  is	  subsequently	  removed	  each	  time	  until	  a	  model	  is	  built	  containing	  only	  one	  feature.	  	  The	  results	  of	  this	  process	  for	  the	  neural	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net	  model	  are	  shown	  in	  Figure	  7.	  	  Average	  error	  in	  predicting	  composition	  of	  mixed	  samples	  from	  the	  model	  built	  using	  three	  donors	  was	  minimized	  using	  a	  combination	  of	  6	  genes	  –	  CCL19,	  XAF1,	  CCL26,	  ALOX15,	  PLCB1,	  and	  RAMP1.	  The	  process	  was	  repeated	  for	  the	  support	  vector	  machine	  model,	  and	  the	  resulting	  accuracy	  over	  number	  of	  features	  is	  shown	  below	  in	  Figure	  7.	  	  Average	  error	  in	  predicting	  composition	  of	  mixed	  samples	  from	  the	  model	  built	  using	  three	  donors	  was	  minimized	  using	  a	  combination	  of	  6	  genes	  –	  ASPHD2,	  CCL26,	  XAF1,	  ALOX15,	  PLCB1,	  and	  CLEC4G.	  	  	  
The	  models	  were	  then	  trained	  using	  the	  genes	  identified	  as	  most	  important	  in	  the	  model’s	  ability	  to	  predict	  sample	  composition,	  and	  the	  results	  are	  shown	  in	  Figure	  8.	  	  The	  neural	  net	  resulting	  from	  training	  the	  data	  using	  the	  six	  genes	  identified	  above	  was	  able	  to	  predict	  sample	  composition	  for	  the	  fourth	  donor	  dataset	  containing	  mixed	  cell	  types	  within	  the	  aforementioned	  criteria,	  with	  an	  average	  error	  in	  prediction	  of	  14.6%	  and	  a	  correlation	  coefficient	  with	  known	  
Figure	  7.	  Feature	  selection	  for	  support	  vector	  machine	  regression	  (right)	  	  and	  neural	  net	  (left)	  models.	  	  
On	  the	  y-­‐axis,	  the	  criteria	  minimized	  during	  the	  process	  was	  the	  average	  error	  in	  predictions	  for	  the	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composition	  of	  0.905.	  However,	  the	  SVM,	  built	  using	  the	  identified	  genes	  above	  did	  not	  meet	  both	  criteria.	  	  While	  the	  model’s	  predictions	  did	  correlate	  linearly	  with	  known	  composition,	  with	  a	  correlation	  coefficient	  of	  0.895,	  the	  variation	  in	  predictions	  led	  to	  an	  average	  error	  of	  14.6%.	  
	  
5.4	  Discussion	  
Overall,	  high	  accuracy	  for	  sample	  composition	  prediction	  was	  achieved	  when	  using	  known	  compositions	  from	  one	  donor	  to	  predict	  other	  sample	  compositions	  from	  that	  same	  donor,	  which	  has	  applications	  in	  understanding	  phenotype	  composition	  changes	  in	  in	  vitro	  samples.	  Several	  different	  model	  types	  performed	  within	  the	  established	  criteria	  using	  data	  from	  one	  donor,	  including	  a	  linear	  and	  
	  
Figure	  8.	  Left	  shows	  the	  fit	  of	  the	  NN	  model	  to	  data	  used	  to	  train	  the	  model	  and	  right	  shows	  the	  
correlation	  of	  predictions	  on	  known	  composition	  for	  the	  fourth	  dataset.	  	  The	  left	  plot	  shows	  the	  
results	  of	  testing	  using	  a	  subset	  of	  the	  data	  used	  to	  train	  the	  model,	  with	  predictions	  on	  the	  y-­‐axis	  
and	  known	  composition	  on	  the	  x-­‐axis.	  	  The	  blue	  line	  shows	  the	  linear	  fit,	  R2	  =	  0.93895.	  In	  the	  
right	  plot,	  the	  predictions	  are	  on	  the	  y-­‐axis,	  vs.	  the	  known	  compositions	  on	  the	  x-­‐axis.	  	  The	  gray	  
line	  represents	  the	  linear	  fit	  for	  the	  known	  composition	  vs.	  predictions,	  R2	  =	  0.81926.	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logistic	  regression	  of	  the	  M1/M2	  expression	  ratio	  onto	  sample	  composition,	  and	  a	  logistic	  regression	  model	  was	  also	  successful	  using	  only	  one	  gene	  for	  each	  phenotype,	  XAF1	  and	  CCL26.	  	  Linear	  regression	  was	  a	  logical	  choice	  to	  fit	  the	  data,	  as	  one	  would	  expect	  expression	  of	  phenotypic	  markers	  to	  increase	  as	  the	  concentration	  of	  that	  phenotype	  increases.	  	  However,	  a	  linear	  fit	  has	  no	  upper	  or	  lower	  bounds,	  and	  since	  we	  are	  predicting	  the	  sample	  composition	  as	  a	  fraction	  of	  M1	  cells	  present	  in	  the	  sample,	  the	  prediction	  should	  fall	  between	  0	  and	  1.	  	  That	  is	  why	  a	  logistic	  regression	  curve	  was	  also	  implemented.	  	  Logistic	  regression	  provides	  an	  odds	  ratio	  estimate	  for	  a	  sample	  to	  fit	  into	  one	  of	  two	  classes,	  in	  this	  case	  0	  (0%	  M1)	  or	  1	  (100%	  M1),	  and	  that	  probability	  can	  be	  used	  to	  estimate	  the	  fraction	  of	  the	  sample	  that	  contains	  M1	  cells.	  	  Thus,	  this	  method	  will	  provide	  predictions	  more	  in	  line	  with	  the	  expected	  sample	  compositions,	  as	  they	  are	  more	  restricted	  in	  range.	  	  However,	  this	  method	  does	  not	  appear	  translational	  to	  other	  datasets,	  as	  depending	  on	  the	  range	  of	  data	  in	  an	  additional	  dataset,	  which	  will	  vary	  between	  donors,	  it	  will	  produce	  odds	  ratios	  greater	  than	  1,	  which	  is	  not	  possible	  as	  a	  fraction	  of	  M1	  cells	  present	  in	  a	  sample.	  
Additionally,	  the	  high	  accuracy	  achieved	  through	  the	  use	  of	  only	  one	  marker	  for	  each	  phenotype	  indicates	  that	  these	  genes	  are	  potentially	  more	  highly	  and	  consistently	  expressed	  across	  the	  spectrum	  of	  macrophages	  termed	  M1,	  for	  XAF1,	  and	  M2,	  for	  CCL26.	  	  As	  the	  M1/M2	  paradigm	  is	  an	  oversimplification	  of	  macrophage	  activation,	  there	  would	  be	  variation	  in	  gene	  expression	  across	  that	  spectrum,	  and	  there	  will	  be	  certain	  markers	  that	  are	  more	  consistent	  across	  that	  spectrum	  for	  each	  phenotype.	  	  This	  could	  also	  cause	  a	  non-­‐linear	  association	  between	  expression	  and	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sample	  composition,	  as	  not	  all	  macrophages	  in	  the	  same	  phenotype	  will	  express	  each	  marker	  to	  the	  same	  degree.	  	  Both	  NN	  and	  SVM	  models	  also	  performed	  well	  when	  testing	  data	  from	  the	  same	  donor	  as	  the	  training	  data.	  	  These	  methods	  are	  designed	  to	  identify	  patterns	  in	  data	  when	  a	  relationship	  is	  not	  already	  defined,	  as	  when	  a	  linear	  or	  logistic	  relationship	  is	  defined	  regardless	  of	  the	  data.	  	  Neural	  networks	  allow	  for	  interactions	  between	  variables	  through	  the	  incorporation	  of	  hidden	  layers,	  and	  in	  this	  instance	  when	  there	  are	  multiple	  markers	  for	  each	  phenotype,	  those	  interactions	  could	  play	  an	  important	  role	  in	  predicting	  composition.	  	  Support	  vector	  machine	  implementations	  utilize	  kernel	  functions	  to	  transform	  the	  data	  and	  model	  the	  relationship	  between	  gene	  expression	  and	  sample	  composition,	  and	  estimate	  the	  similarity	  between	  samples	  and	  incorporate	  that	  into	  the	  prediction.	  
However,	  the	  overall	  goal	  of	  the	  project	  was	  to	  create	  a	  model	  that	  could	  successfully	  predict	  sample	  composition	  within	  the	  desired	  accuracy	  range	  on	  in	  
vivo	  samples	  as	  well	  as	  in	  vitro,	  and	  in	  that	  instance,	  a	  standard	  curve	  is	  not	  possible.	  Models	  trained	  using	  data	  from	  one	  donor	  and	  tested	  using	  data	  from	  a	  separate	  dataset	  did	  not	  meet	  the	  established	  accuracy	  constraints.	  	  This	  could	  be	  attributed	  both	  to	  natural	  variations	  between	  donors,	  but	  also	  to	  the	  batch	  effects	  that	  are	  always	  accrued	  in	  separate	  experimental	  runs.	  To	  improve	  the	  model’s	  ability	  to	  incorporate	  donor-­‐to-­‐donor	  variability,	  models	  were	  built	  using	  all	  three	  donors	  and	  feature	  selection	  was	  applied	  to	  determine	  the	  ideal	  number	  of	  genes	  to	  include	  in	  the	  model	  to	  minimize	  prediction	  error.	  	  After	  this	  process,	  a	  neural	  net	  using	  six	  input	  genes	  and	  consisting	  of	  15	  hidden	  layers	  met	  the	  desired	  predictive	  accuracy.	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As	  mentioned	  above,	  neural	  networks	  are	  able	  to	  use	  hidden	  layers	  that	  incorporate	  interactions	  between	  variables	  to	  improve	  their	  predictive	  ability,	  and	  the	  interaction	  of	  this	  combination	  of	  genes	  provided	  the	  best	  output.	  	  It	  is	  possible	  that	  there	  are	  interactions	  between	  markers	  of	  different	  phenotypes	  that	  contribute	  to	  the	  composition	  prediction	  and	  a	  neural	  net	  is	  able	  to	  infer	  that	  relationship.	  	  	  
These	  results	  indicate	  that	  certain	  genes	  are	  more	  useful	  at	  predicting	  sample	  composition	  than	  others.	  	  Optimizing	  the	  included	  genes	  can	  lead	  to	  improved	  accuracy,	  which	  is	  the	  goal	  of	  feature	  selection.	  	  These	  results	  are	  consistent	  with	  similar	  work	  in	  which	  gene	  expression	  was	  used	  to	  classify	  dendritic	  cell	  phenotype,	  and	  the	  list	  of	  potential	  genes	  was	  shortened	  at	  each	  step	  to	  find	  the	  fewest	  possible	  genes	  that	  produced	  the	  most	  accurate	  predictions	  [26].	  It	  is	  also	  possible	  that	  several	  of	  the	  genes	  for	  each	  phenotype	  have	  the	  same	  expression	  trends	  with	  respect	  to	  sample	  composition,	  so	  it	  is	  not	  necessary	  to	  include	  all	  of	  them	  to	  infer	  the	  same	  relationship,	  and	  the	  addition	  of	  more	  genes	  will	  not	  significantly	  improve	  the	  results.	  	  Feature	  selection	  can	  zero	  in	  on	  the	  genes	  necessary	  to	  gain	  an	  accurate	  prediction,	  increasing	  both	  the	  efficiency	  and	  cost	  of	  the	  model	  by	  requiring	  less	  data	  as	  input.	  
The	  neural	  net	  resulting	  from	  training	  the	  data	  using	  the	  six	  genes	  identified	  through	  feature	  selection	  was	  able	  to	  successfully	  predict	  sample	  composition	  for	  the	  test	  dataset	  containing	  mixed	  cell	  types.	  However,	  the	  SVM	  built	  using	  the	  identified	  genes	  above	  still	  failed	  to	  meet	  the	  established	  criteria.	  	  In	  testing	  using	  a	  different	  number	  of	  input	  genes,	  it	  appears	  that	  the	  SVM	  consistently	  minimizes	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error	  by	  driving	  predictions	  towards	  a	  50%	  estimate,	  and	  so	  is	  not	  an	  optimal	  method	  for	  this	  project.	  	  This	  is	  why	  the	  additional	  criteria	  of	  a	  correlation	  with	  known	  composition	  was	  included,	  to	  ensure	  the	  predictions	  were	  linearly	  increasing	  with	  sample	  composition	  in	  addition	  to	  minimizing	  error.	  	  	  	  
Overall,	  Aim	  2	  successfully	  resulted	  in	  a	  model	  that	  can	  be	  used	  to	  predict	  the	  M1/M2	  composition	  of	  a	  heterogeneous	  sample	  within	  the	  accuracy	  desired.	  	  Incorporating	  multiple	  donors	  into	  the	  training	  potentially	  allowed	  the	  model	  to	  account	  for	  variability	  in	  donor-­‐to-­‐donor	  expression,	  resulting	  in	  more	  accurate	  predictions	  than	  models	  trained	  on	  only	  one	  or	  two	  donors,	  as	  those	  may	  over	  fit	  to	  that	  particular	  data	  and	  will	  not	  be	  translatable	  to	  samples	  from	  other	  donors,	  or	  samples	  containing	  data	  from	  multiple	  donors,	  as	  could	  be	  the	  case	  in	  in	  vitro	  experimentation.	  	  This	  approach	  is	  consistent	  with	  other	  studies	  in	  which	  training	  data	  consists	  of	  a	  combination	  of	  experimental	  data	  [26,	  46],	  so	  as	  not	  to	  over	  fit	  to	  any	  particular	  donor.	  	  There	  is	  potential	  for	  improvement	  in	  the	  models,	  with	  the	  generation	  of	  more	  training	  data	  and	  validation	  data	  to	  improve	  the	  accuracy	  of	  the	  models	  beyond	  the	  neural	  net.	  A	  limitation	  of	  neural	  nets	  is	  their	  sensitivity	  to	  initial	  conditions,	  and	  so	  training	  multiple	  times	  can	  result	  in	  different	  node	  weight	  configurations	  and	  thus	  different	  predictions,	  even	  if	  the	  same	  training	  data	  is	  used.	  	  Additionally,	  feature	  selection	  could	  be	  applied	  earlier	  in	  the	  process	  when	  determining	  markers	  rather	  than	  relying	  on	  pre-­‐established	  thresholds	  to	  narrow	  the	  gene	  set.	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6.	  Aim	  3:	  Characterize	  macrophage	  behavior	  in	  heterogeneous	  tissue.	  
6.1	  Experimental	  Design	  
Several	  publicly	  available	  datasets	  were	  identified	  that	  provided	  gene	  expression	  data	  from	  wound	  tissue	  for	  analysis	  of	  macrophage	  behavior	  in	  this	  environment.	  	  As	  this	  data	  was	  all	  generated	  using	  platforms	  other	  than	  the	  RT-­‐PCR	  method	  used	  to	  generate	  training	  data	  used	  in	  model	  development,	  the	  trends	  of	  the	  genes	  identified	  as	  optimal	  input	  for	  the	  model	  in	  Aim	  2	  was	  first	  assessed	  over	  all	  samples.	  	  Data	  from	  the	  first	  dataset	  was	  used	  as	  input	  to	  the	  model,	  as	  macrophage	  behavior	  in	  acute	  wound	  healing	  has	  been	  well	  described,	  and	  can	  be	  used	  to	  assess	  the	  validity	  of	  these	  results.	  	  	  
6.2	  Methods	  
Three	  datasets	  were	  identified	  that	  consisted	  of	  gene	  expression	  data	  of	  heterogeneous	  tissue	  originating	  from	  skin	  wounds.	  	  These	  datasets,	  and	  the	  samples	  contained	  therein,	  are	  summarized	  in	  table	  12	  below,	  and	  the	  methods	  for	  generation	  of	  each	  dataset	  can	  be	  found	  in	  the	  associated	  publication.	  
1.	  Datasets	  used	  for	  tracking	  macrophage	  behavior	  over	  time	  using	  identified	  genes	  
Identifier	   Samples	   Time	  Points	   Controls	  GSE28914	  [47]	   Split-­‐thickness	  skin	  graft	  donor	  site	  wounds	   Days	  0,	  3,	  and	  7	   Intact	  skin	  at	  day	  0	  GSE56803	  [48]	   Skin	  following	  wound	  via	  suction	  blister	   Weeks	  1,	  2,	  4,	  6	  and	  16	   Intact	  skin	  at	  each	  time	  point	  E-­‐MTAB-­‐1323	  [49]	   Skin	  following	  burn	  injury	   Hour	  1	  and	  weeks	  1,	  4,	  7,	  and	  13	   Intact	  skin	  at	  day	  0	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All	  data	  was	  log	  base	  2	  normalized,	  and	  then	  the	  fold	  change	  over	  the	  respective	  control	  for	  that	  sample	  was	  calculated	  to	  account	  for	  variation	  between	  donors.	  	  Expression	  for	  each	  of	  the	  six	  genes	  identified	  in	  Aim	  2	  –	  XAF1,	  CCL19,	  CCL26,	  RAMP1,	  PLCB1,	  and	  ALOX15-­‐	  was	  assessed	  over	  time.	  	  Overall	  differences	  among	  the	  time	  points	  for	  each	  set	  were	  assessed	  using	  a	  one-­‐way	  ANOVA,	  and	  the	  groups	  responsible	  for	  those	  differences	  were	  identified	  using	  Tukey’s	  post-­‐hoc	  analysis.	  	  These	  expression	  values	  were	  then	  inputted	  to	  the	  neural	  net	  model	  developed	  in	  Aim	  2.	  
6.3	  Results	  	  
	   Expression	  trends	  for	  the	  six	  genes	  in	  the	  first	  dataset,	  looking	  at	  split-­‐thickness	  skin	  graft	  wounds,	  can	  be	  seen	  in	  Figure	  9.	  
Figure	  9.	  Plots	  of	  mean	  gene	  expression	  from	  GSE28914	  over	  time	  with	  standard	  deviation.	  	  The	  x-­‐axis	  shows	  
the	  three	  time	  points	  (n=6	  for	  day	  0	  and	  day	  3	  and	  n=5	  for	  day	  7)	  and	  the	  y-­‐axis	  is	  the	  fold-­‐change	  over	  intact	  
skin.	  	  The	  scales	  on	  the	  y-­‐axis	  are	  slightly	  different	  to	  reflect	  the	  best	  range	  for	  that	  gene's	  data.	  *	  <	  0.05,	  **	  <	  
0.01,	  Tukey’s	  post-­‐hoc	  analysis	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In	  Figure	  9,	  three	  of	  the	  six	  genes	  vary	  significantly	  over	  time.	  	  Both	  of	  the	  M1	  markers	  increase	  expression	  relative	  to	  intact	  skin	  at	  day	  3,	  and	  return	  to	  baseline	  by	  day	  7.	  	  Very	  little	  change	  was	  seen	  in	  M2	  expression,	  except	  in	  PLCB1,	  whose	  expression	  relative	  to	  intact	  skin	  decreased	  over	  time.	  
	   Expression	  trends	  for	  the	  six	  genes	  in	  the	  second	  dataset,	  looking	  at	  skin	  following	  suction	  blister	  over	  a	  much	  longer	  time	  frame	  than	  is	  seen	  in	  the	  first	  dataset,	  is	  shown	  in	  Figure	  10.	  
Figure	  10.	  Plots	  of	  mean	  gene	  expression	  from	  GSE56803	  over	  time	  with	  standard	  deviation.	  	  The	  x-­‐axis	  shows	  
the	  time	  points	  (n=14	  at	  each	  time,	  except	  n=13	  at	  wk4)	  and	  the	  y-­‐axis	  is	  the	  fold-­‐change	  over	  intact	  skin.	  	  The	  
scales	  on	  the	  y-­‐axis	  are	  slightly	  different	  to	  reflect	  the	  best	  range	  for	  that	  gene's	  data.	  *	  <	  0.05,	  **	  <	  0.01,	  
Tukey’s	  post-­‐hoc	  analysis	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None	  of	  these	  genes	  varied	  significantly	  over	  time.	  	  There	  was	  great	  variation	  within	  the	  samples	  at	  each	  time	  point,	  and	  so	  there	  were	  no	  strong	  trends	  seen	  for	  any	  of	  these	  genes	  across	  the	  sample	  groups.	  	  	  
	   Finally,	  expression	  of	  these	  genes	  in	  a	  third	  dataset,	  including	  samples	  from	  skin	  tissue	  following	  a	  burn	  injury,	  is	  shown	  in	  Figure	  11.	  
	   	  
For	  the	  third	  dataset,	  analyzing	  skin	  samples	  following	  burn	  injury,	  three	  genes	  varied	  significantly	  over	  time.	  	  The	  M1	  genes	  increased	  expression	  by	  around	  1	  week	  following	  injury,	  before	  decreasing.	  	  Both	  RAMP1	  and	  PLCB1	  decreased	  expression	  over	  extended	  periods	  of	  time.	  
Figure	  11.	  Plots	  of	  mean	  gene	  expression	  from	  E-­‐MTAB-­‐1323	  over	  time	  with	  standard	  deviation.	  	  The	  
x-­‐axis	  shows	  the	  time	  points	  (n=5	  at	  each	  time	  point)	  and	  the	  y-­‐axis	  is	  the	  fold-­‐change	  over	  intact	  
skin.	  	  The	  scales	  on	  the	  y-­‐axis	  are	  slightly	  different	  to	  reflect	  the	  best	  range	  for	  that	  gene's	  data.	  *	  <	  
0.05,	  **	  <	  0.01,	  Tukey’s	  post-­‐hoc	  analysis	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   Log	  base	  2	  normalized	  expression	  data	  from	  the	  first	  dataset	  was	  used	  as	  input	  for	  the	  neural	  net	  described	  in	  Aim	  2.	  	  Predictions	  of	  relative	  M1/M2	  sample	  composition	  for	  each	  time	  point	  are	  shown	  in	  Figure	  12.	  
The	  trend	  seen	  here	  shows	  that	  immediately	  following	  wounding,	  the	  tissue	  is	  dominated	  by	  the	  M1	  phenotype,	  and	  it	  transitions	  to	  a	  more	  even	  distribution	  by	  day	  7.	  	  Sample	  composition	  predictions	  at	  day	  7	  are	  significantly	  different	  from	  the	  predictions	  at	  day	  0.	  	  As	  expected	  based	  on	  the	  lack	  of	  individual	  gene	  expression	  variation	  in	  the	  suction	  wound	  dataset,	  predictions	  did	  not	  vary	  over	  time.	  	  Finally,	  on	  the	  burn	  wound	  dataset,	  M1	  composition	  increased	  immediately	  following	  injury,	  decreased	  at	  week	  1,	  and	  then	  increased	  again	  for	  the	  remainder	  of	  the	  study,	  possibly	  representing	  the	  chronic	  inflammatory	  nature	  of	  these	  wounds.	  
6.4	  Discussion	  
The	  genes	  identified	  in	  Aims	  1	  and	  2	  showed	  promise	  in	  identifying	  M1	  macrophage	  behavior	  trends	  based	  on	  data	  from	  in	  vivo	  samples.	  	  However,	  M2	  gene	  
Figure	  12.	  Plot	  of	  mean	  predicted	  sample	  composition	  of	  acute	  wound	  healing	  (left),	  suction	  wounds	  
(center),	  and	  burn	  wounds	  (right)	  over	  time	  with	  standard	  deviation.	  	  The	  x-­‐axis	  shows	  the	  time	  points	  
(n=6	  at	  day	  0	  and	  3,	  n=5	  at	  day	  7)	  and	  the	  y-­‐axis	  is	  fraction	  M1	  cells	  in	  the	  sample.	  *	  <	  0.05,	  **	  <	  0.01,	  
Tukey’s	  post-­‐hoc	  analysis	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expression	  did	  not	  vary	  as	  much	  as	  expected	  in	  the	  in	  vivo	  samples.	  	  Typical	  wound	  healing	  expects	  an	  initial	  influx	  of	  M1	  macrophages	  as	  part	  of	  the	  inflammatory	  phase,	  followed	  by	  an	  increase	  in	  M2	  macrophages	  as	  part	  of	  the	  healing	  phase	  [50].	  	  This	  influx	  of	  M1	  macrophages	  was	  seen,	  both	  when	  looking	  at	  gene	  expression	  trends	  in	  each	  dataset,	  and	  when	  the	  model	  was	  used	  to	  predict	  sample	  composition	  in	  the	  data	  representative	  of	  acute	  wound	  healing.	  	  It	  appears	  that	  the	  decrease	  in	  predicted	  volume	  of	  M1	  cells,	  and	  subsequent	  increase	  in	  M2	  cells	  shown	  in	  the	  model’s	  predictions	  were	  driven	  by	  expression	  of	  M1	  cells,	  based	  on	  the	  evaluation	  of	  individual	  gene	  trends.	  
These	  results	  indicate	  that	  in	  vitro	  polarized	  M2	  macrophages	  may	  not	  accurately	  represent	  the	  macrophage	  phenotype	  present	  as	  M2	  in	  the	  wound	  environment.	  	  There	  is	  also	  another	  identified	  M2	  phenotype	  involved	  in	  the	  wound	  healing	  process,	  M2c,	  polarized	  using	  interleukin-­‐10	  [51],	  and	  it	  is	  possible	  that	  that	  phenotype	  is	  driving	  the	  expected	  M2	  behaviors	  in	  the	  wound	  instead.	  	  The	  lack	  of	  variation	  in	  expression	  of	  the	  M2	  genes	  in	  the	  majority	  of	  the	  test	  datasets,	  despite	  the	  combination	  of	  in	  vitro	  datasets	  used	  to	  identify	  the	  markers,	  indicates	  that	  the	  polarization	  methods	  used	  to	  generate	  the	  M2	  macrophages	  in	  vitro	  is	  not	  replicating	  the	  phenotype	  performing	  M2	  related	  functions	  in	  the	  wound.	  
The	  model	  did	  successfully	  replicate	  the	  trends	  we	  would	  expect	  to	  see	  in	  acute	  wound	  healing,	  using	  data	  from	  a	  different	  platform	  than	  used	  to	  train	  the	  model.	  Had	  data	  collection	  in	  the	  study	  that	  produced	  the	  first	  dataset	  continued,	  the	  M2	  composition	  would	  be	  expected	  to	  increase,	  before	  returning	  to	  baseline	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following	  healing.	  However,	  it	  is	  important	  to	  note	  that	  there	  is	  no	  incorporation	  for	  the	  model	  to	  show	  overall	  low	  concentrations	  of	  M1	  and	  M2	  macrophages	  combined,	  as	  it	  returns	  a	  relative	  composition.	  	  
Additionally,	  because	  this	  data	  was	  generated	  on	  a	  different	  platform	  (microarray	  vs.	  RT-­‐PCR),	  further	  model	  validation	  is	  needed	  with	  data	  originating	  from	  samples	  of	  known	  composition	  generated	  on	  those	  platforms.	  	  The	  model	  currently	  predicts	  a	  greater	  than	  100%	  M1	  composition	  in	  certain	  samples,	  which	  is	  not	  possible.	  	  This	  could	  be	  due	  to	  differences	  in	  the	  platform	  used	  to	  generate	  this	  test	  data	  vs.	  the	  original	  training	  data.	  	  It	  also	  provides	  an	  area	  of	  improvement	  for	  the	  model,	  in	  which	  an	  upper	  threshold	  could	  be	  defined	  so	  that	  the	  predictions	  are	  forced	  between	  0	  and	  1.	  	  There	  is	  potential	  to	  apply	  the	  model	  and	  gene	  signatures	  to	  additional	  datasets	  involving	  heterogeneous	  wound	  samples,	  and	  future	  work	  will	  incorporate	  that	  application,	  as	  well	  as	  increased	  scrutiny	  of	  the	  model	  across	  platforms	  and	  with	  in	  vivo	  data.	  
7.	  Conclusion	  
The	  method	  presented	  here	  to	  identify	  genes	  capable	  of	  inferring	  relative	  macrophage	  phenotype	  composition	  in	  a	  heterogeneous	  sample	  was	  successful,	  both	  in	  creating	  models	  that	  can	  use	  a	  standard	  curve	  to	  infer	  composition	  from	  samples	  originating	  from	  the	  same	  donor	  as	  those	  used	  to	  build	  the	  model,	  and	  in	  developing	  models	  that	  are	  trained	  on	  multiple	  donors	  to	  incorporate	  variability	  and	  predict	  composition	  on	  samples	  from	  a	  separate	  donor,	  even	  in	  the	  presence	  of	  additional	  cell	  types.	  	  The	  success	  criteria,	  obtained	  from	  the	  literature	  in	  studies	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with	  similar	  goals,	  were	  defined	  as	  predictions	  averaging	  less	  than	  15%	  error,	  and	  predictions	  that	  correlated	  with	  known	  composition,	  to	  the	  degree	  at	  which	  the	  Pearson	  product-­‐moment	  correlation	  coefficient	  exceeds	  0.9	  in	  value.	  	  The	  two	  most	  successful	  models	  were	  support	  vector	  machines	  and	  neural	  nets,	  which	  have	  been	  employed	  in	  various	  studies	  to	  make	  predictions	  based	  on	  gene	  expression,	  both	  in	  classification	  [26],	  and	  in	  predicting	  relative	  cell	  type	  frequencies	  [25].	  	  Out	  of	  this	  work,	  we	  provide	  an	  SVM	  and	  NN	  trained	  using	  samples	  with	  known	  composition	  from	  three	  donors,	  and	  verified	  on	  samples	  created	  with	  cells	  from	  three	  separate	  donors	  (monocytes	  polarized	  to	  macrophage	  phenotypes,	  fibroblasts,	  and	  endothelial	  cells).	  	  	  
Additionally,	  for	  in	  vitro	  work,	  future	  users	  can	  create	  a	  standard	  curve	  consisting	  of	  samples	  with	  known	  composition	  and	  fit	  a	  logistic	  regression	  to	  gene	  expression	  data	  from	  those	  samples,	  and	  use	  that	  to	  infer	  sample	  composition	  of	  experimental	  in	  vitro	  samples	  from	  that	  donor	  if	  composition	  is	  not	  known,	  using	  three	  M1	  genes	  and	  six	  M2	  genes.	  	  This	  method	  does	  not	  depend	  on	  the	  user	  having	  access	  and	  training	  to	  equipment	  for	  flow	  cytometry	  approaches,	  and	  does	  not	  require	  the	  expense	  or	  computational	  workload	  of	  whole	  genome	  analysis,	  which	  is	  the	  data	  type	  that	  many	  deconvolution	  methods	  have	  incorporated.	  
The	  genes	  identified	  here	  were	  used	  to	  infer	  relative	  M1	  and	  M2	  macrophage	  composition	  in	  publicly	  available	  datasets.	  	  Based	  on	  the	  ability	  of	  the	  expression	  of	  these	  genes	  to	  predict	  composition	  in	  samples	  where	  composition	  is	  known,	  it	  was	  inferred	  that	  they	  could	  provide	  information	  regarding	  the	  M1	  and	  M2	  frequency	  in	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unknown	  samples.	  	  This	  concept	  was	  applied	  in	  the	  analysis	  of	  a	  publicly	  available	  dataset,	  and	  the	  results	  indicate	  changes	  in	  the	  macrophage	  dominant	  behavior	  over	  time	  in	  ways	  that	  appear	  physiologically	  relevant,	  but	  also	  reveal	  the	  need	  for	  further	  validation	  of	  the	  model	  across	  data	  generation	  platforms,	  and	  in	  regards	  to	  
in	  vivo	  data.	  
There	  are	  limitations	  to	  the	  predictive	  ability	  of	  the	  model	  overall.	  	  All	  training	  data	  consisted	  of	  cells	  cultured	  in	  vitro,	  and	  so	  they	  will	  not	  completely	  represent	  their	  in	  vivo	  counterparts.	  	  Additionally,	  heterogeneous	  tissue	  samples	  will	  have	  additional	  cell	  types,	  though	  most	  likely	  not	  as	  present	  as	  those	  discussed	  here,	  but	  expression	  from	  those	  cell	  types	  could	  potentially	  interfere	  with	  predictive	  ability.	  	  Future	  work	  will	  aim	  to	  overcome	  these	  limitations	  through	  further	  testing	  with	  in	  vivo	  data	  in	  scenarios	  where	  we	  have	  high	  confidence	  in	  the	  expected	  macrophage	  behavioral	  trends.	  	  Additionally,	  the	  model	  could	  be	  expanded	  to	  different	  sample	  types	  beyond	  the	  wound	  and	  skin	  environment.	  Macrophage	  activation	  is	  more	  complex	  than	  the	  M1-­‐M2	  paradigm	  described	  here,	  and	  so	  future	  efforts	  could	  incorporate	  other	  described	  macrophage	  phenotypes	  into	  the	  predictive	  capabilities	  of	  the	  model,	  though	  more	  work	  is	  necessary	  to	  understand	  the	  function	  and	  unique	  gene	  expression	  of	  those	  additional	  phenotypes.	  	  Finally,	  the	  model	  has	  currently	  only	  been	  applied	  to	  data	  generated	  from	  microarrays,	  and	  as	  it	  was	  developed	  with	  the	  intent	  of	  using	  RT-­‐PCR,	  it	  will	  need	  to	  be	  applied	  to	  samples	  analyzed	  on	  that	  platform.	  The	  model	  presented	  here	  is	  a	  useful	  starting	  point	  and	  can	  reveal	  important	  information	  regarding	  sample	  composition	  and	  potential	  timing	  of	  phenotype	  switching.	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Appendix	  A.	  Final	  Neural	  Net	  Weights	  
2.35295271876943	  -­‐1.76847210743488	  1.79733092697965	  1.25958278826310	  0.973877668626867	  0.899697273452229	  -­‐0.544157962774647	  -­‐0.0859129744337178	  -­‐0.289799638899853	  0.813806184592806	  1.10774412846866	  -­‐1.18134132776750	  1.59394560318195	  1.16595301867053	  -­‐2.29005955402673	  0.0402163462050595	  0.728212496389712	  -­‐1.23263503962090	  -­‐0.0665663000016871	  -­‐0.893266479972100	  -­‐0.0727684121710450	  1.00654991160341	  -­‐0.713913162697875	  -­‐0.210526847944204	  1.42125159879482	  1.42969028217503	  -­‐0.624621464269170	  0.346112188922919	  1.00235503689970	  -­‐0.614532069823347	  0.557234500961548	  -­‐1.85138880203629	  -­‐0.395499024957336	  0.930840751117696	  -­‐0.600305911690968	  1.18804423239507	  0.0225714799625407	  -­‐1.26750939959293	  0.445768983989950	  0.271341960307924	  1.33314816913129	  -­‐0.202770194213475	  1.44348232963612	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-­‐0.353077697581578	  0.216305334723235	  -­‐1.15424235151822	  0.164230832639196	  1.32910648478830	  -­‐1.06711346659388	  1.17479495777420	  -­‐0.917902786033922	  1.10232493464109	  -­‐0.754521896282412	  1.58167396653391	  -­‐0.700783494537327	  0.466942884705545	  -­‐0.920868453130708	  -­‐0.305315951318374	  -­‐1.88891825926456	  0.0525295605262906	  1.27967922797936	  -­‐1.06856462661677	  0.646071267894877	  1.43154890051035	  0.0898323521760091	  0.843821146150661	  0.951097220485709	  1.01108319013479	  -­‐0.404511809264165	  -­‐1.39290650740146	  1.09301308227362	  1.33699340853142	  0.337453238801733	  0.329687384304959	  -­‐1.25062431572285	  -­‐1.20173292473558	  -­‐0.0767296046840564	  0.274694593846690	  0.690761461084366	  0.813568379267208	  -­‐1.27826295431741	  -­‐1.34265656594135	  -­‐0.704127954153617	  -­‐1.15203439691323	  -­‐0.362560981626798	  0.415332629198330	  0.479512302630736	  -­‐0.381346145129079	  -­‐1.06104356985787	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Appendix	  B.	  Neural	  net	  code	  
function [err] = neuralnetFS(x,t) 
  
x = x'; 
t = t'; 
  
% Training Function 
trainFcn = 'trainlm';  % Levenberg-Marquardt backpropagation. 
  
% Create a Fitting Network 
hiddenLayerSize = 1; 
net = fitnet(hiddenLayerSize,trainFcn); 
  
% Setup Division of Data for Training, Validation, Testing 
net.divideParam.trainRatio = 70/100; 
net.divideParam.valRatio = 15/100; 
net.divideParam.testRatio = 15/100; 
  
% Train the Network 
net.trainParam.showWindow = false; 
[net,tr] = train(net,x,t); 
  
% Test the Network 
y = net(x); 
e = gsubtract(t,y); 
err = mean(abs(e)); 



























Appendix	  C.	  Log	  normalized	  gene	  expression	  over	  GAPDH	  training	  data	  
Composition	   ASPHD2	   CCL19	   XAF1	   CCL26	   CLEC4G	   ALOX15	   PLCB1	   RAMP1	   WNT5B	  
1	   -­‐2.204	   -­‐2.944	   -­‐1.481	   -­‐4.278	   -­‐6.719	   -­‐6.761	   -­‐3.356	   -­‐3.510	   -­‐6.719	  
1	   -­‐2.523	   -­‐2.857	   -­‐1.129	   -­‐4.229	   -­‐5.292	   -­‐6.876	   -­‐3.353	   -­‐3.904	   -­‐5.548	  
1	   -­‐3.010	   -­‐2.896	   -­‐1.887	   -­‐4.389	   -­‐4.543	   -­‐6.863	   -­‐3.507	   -­‐3.588	   -­‐6.803	  
1	   -­‐1.800	   -­‐2.715	   -­‐1.096	   -­‐4.103	   -­‐6.794	   -­‐4.549	   -­‐3.636	   -­‐5.208	   -­‐6.794	  
1	   -­‐1.924	   -­‐2.965	   -­‐1.698	   -­‐4.242	   -­‐6.385	   -­‐4.461	   -­‐3.197	   -­‐4.100	   -­‐6.385	  
0.75	   -­‐2.204	   -­‐2.845	   -­‐1.532	   -­‐2.315	   -­‐5.066	   -­‐2.556	   -­‐3.128	   -­‐3.384	   -­‐5.298	  
0.75	   -­‐2.523	   -­‐3.134	   -­‐1.818	   -­‐2.640	   -­‐5.202	   -­‐2.788	   -­‐3.254	   -­‐3.594	   -­‐6.860	  
0.75	   -­‐3.010	   -­‐2.932	   -­‐2.059	   -­‐2.757	   -­‐5.467	   -­‐2.691	   -­‐4.016	   -­‐2.751	   -­‐6.957	  
0.75	   -­‐1.800	   -­‐3.061	   -­‐2.122	   -­‐5.021	   -­‐5.376	   -­‐2.532	   -­‐3.645	   -­‐2.718	   -­‐6.879	  
0.75	   -­‐1.924	   -­‐2.986	   -­‐2.065	   -­‐4.001	   -­‐6.791	   -­‐2.670	   -­‐3.254	   -­‐2.821	   -­‐6.791	  
0.5	   -­‐3.179	   -­‐3.052	   -­‐2.405	   -­‐2.390	   -­‐6.144	   -­‐2.222	   -­‐3.278	   -­‐2.258	   -­‐6.701	  
0.5	   -­‐3.332	   -­‐3.338	   -­‐2.417	   -­‐2.432	   -­‐5.822	   -­‐2.155	   -­‐3.248	   -­‐2.426	   -­‐6.674	  
0.5	   -­‐2.806	   -­‐3.471	   -­‐2.086	   -­‐2.324	   -­‐6.060	   -­‐2.041	   -­‐3.248	   -­‐2.541	   -­‐6.716	  
0.5	   -­‐3.001	   -­‐3.477	   -­‐2.354	   -­‐2.318	   -­‐5.539	   -­‐2.098	   -­‐3.137	   -­‐2.565	   -­‐6.701	  
0.5	   -­‐2.465	   -­‐3.049	   -­‐1.586	   -­‐1.818	   -­‐5.066	   -­‐1.848	   -­‐2.622	   -­‐2.462	   -­‐5.452	  
0.5	   -­‐3.031	   -­‐3.372	   -­‐2.173	   -­‐1.993	   -­‐4.979	   -­‐2.056	   -­‐2.881	   -­‐2.231	   -­‐6.680	  
0.25	   -­‐2.908	   -­‐3.501	   -­‐2.017	   -­‐1.710	   -­‐4.687	   -­‐1.611	   -­‐2.724	   -­‐2.348	   -­‐6.198	  
0.25	   -­‐3.086	   -­‐3.546	   -­‐2.240	   -­‐1.890	   -­‐4.675	   -­‐1.878	   -­‐2.682	   -­‐2.396	   -­‐6.686	  
0.25	   -­‐2.959	   -­‐3.555	   -­‐1.921	   -­‐1.875	   -­‐5.069	   -­‐1.728	   -­‐2.496	   -­‐2.438	   -­‐6.854	  
0.25	   -­‐2.757	   -­‐3.507	   -­‐2.273	   -­‐1.930	   -­‐4.829	   -­‐1.665	   -­‐2.562	   -­‐2.459	   -­‐6.845	  
0.25	   -­‐1.996	   -­‐3.083	   -­‐1.734	   -­‐1.743	   -­‐4.028	   -­‐1.737	   -­‐2.354	   -­‐2.342	   -­‐6.701	  
0.25	   -­‐2.462	   -­‐3.296	   -­‐2.258	   -­‐1.710	   -­‐4.329	   -­‐1.731	   -­‐2.411	   -­‐2.508	   -­‐6.770	  
0	   -­‐3.375	   -­‐4.407	   -­‐2.523	   -­‐2.471	   -­‐4.889	   -­‐2.074	   -­‐3.137	   -­‐2.306	   -­‐5.720	  
0	   -­‐3.627	   -­‐3.486	   -­‐2.736	   -­‐1.421	   -­‐3.706	   -­‐1.189	   -­‐2.240	   -­‐1.358	   -­‐5.075	  
0	   -­‐3.718	   -­‐2.529	   -­‐2.914	   -­‐1.632	   -­‐3.486	   -­‐1.252	   -­‐2.312	   -­‐1.623	   -­‐4.254	  
0	   -­‐2.670	   -­‐2.739	   -­‐2.628	   -­‐1.713	   -­‐3.516	   -­‐1.379	   -­‐2.303	   -­‐1.716	   -­‐4.335	  
0.8	   -­‐2.914	   -­‐4.914	   -­‐2.270	   -­‐2.550	   -­‐4.368	   -­‐1.192	   -­‐3.820	   -­‐3.146	   -­‐5.635	  
0.8	   -­‐2.550	   -­‐4.082	   -­‐2.179	   -­‐2.721	   -­‐4.175	   -­‐1.322	   -­‐3.661	   -­‐3.004	   -­‐6.703	  
0.8	   -­‐2.640	   -­‐4.405	   -­‐1.854	   -­‐2.616	   -­‐3.907	   -­‐1.481	   -­‐3.688	   -­‐3.170	   -­‐6.213	  
0.8	   -­‐2.700	   -­‐3.962	   -­‐1.978	   -­‐2.387	   -­‐3.667	   -­‐1.430	   -­‐3.612	   -­‐2.682	   -­‐6.509	  
0.7	   -­‐2.682	   -­‐4.629	   -­‐1.921	   -­‐2.456	   -­‐3.940	   -­‐1.373	   -­‐3.648	   -­‐2.992	   -­‐5.362	  
0.7	   -­‐2.757	   -­‐4.175	   -­‐2.089	   -­‐2.336	   -­‐3.748	   -­‐1.258	   -­‐3.597	   -­‐2.775	   -­‐6.403	  
0.7	   -­‐2.619	   -­‐4.590	   -­‐1.770	   -­‐2.318	   -­‐4.055	   -­‐1.319	   -­‐3.600	   -­‐3.242	   -­‐6.114	  
0.7	   -­‐2.899	   -­‐4.371	   -­‐2.008	   -­‐2.375	   -­‐3.931	   -­‐1.367	   -­‐3.718	   -­‐3.359	   -­‐5.551	  
0.6	   -­‐2.809	   -­‐4.398	   -­‐2.372	   -­‐2.414	   -­‐4.365	   -­‐1.198	   -­‐3.576	   -­‐3.016	   -­‐6.623	  
0.6	   -­‐3.128	   -­‐4.959	   -­‐2.664	   -­‐2.185	   -­‐4.585	   -­‐0.906	   -­‐3.579	   -­‐3.158	   -­‐6.020	  
0.5	   -­‐2.730	   -­‐4.245	   -­‐2.149	   -­‐2.173	   -­‐4.109	   -­‐0.978	   -­‐3.359	   -­‐3.016	   -­‐5.509	  
0.5	   -­‐2.806	   -­‐4.371	   -­‐2.369	   -­‐2.083	   -­‐4.163	   -­‐0.999	   -­‐3.248	   -­‐3.158	   -­‐6.328	  
0.5	   -­‐3.101	   -­‐4.682	   -­‐2.113	   -­‐2.201	   -­‐4.148	   -­‐0.996	   -­‐3.215	   -­‐2.577	   -­‐6.421	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0.5	   -­‐2.806	   -­‐4.476	   -­‐1.806	   -­‐2.198	   -­‐4.040	   -­‐1.132	   -­‐3.363	   -­‐2.932	   -­‐7.014	  
0.4	   -­‐2.911	   -­‐4.602	   -­‐2.107	   -­‐2.231	   -­‐4.299	   -­‐1.120	   -­‐3.438	   -­‐2.827	   -­‐6.963	  
0.4	   -­‐2.794	   -­‐4.575	   -­‐1.854	   -­‐2.116	   -­‐4.485	   -­‐1.138	   -­‐3.462	   -­‐2.869	   -­‐6.018	  
0.4	   -­‐3.311	   -­‐5.211	   -­‐2.827	   -­‐1.746	   -­‐4.593	   -­‐0.677	   -­‐3.203	   -­‐3.049	   -­‐5.015	  
0.4	   -­‐3.314	   -­‐4.648	   -­‐2.198	   -­‐2.164	   -­‐4.567	   -­‐0.840	   -­‐3.077	   -­‐2.989	   -­‐5.500	  
0.3	   -­‐4.193	   -­‐5.229	   -­‐3.164	   -­‐1.740	   -­‐4.154	   -­‐0.548	   -­‐2.544	   -­‐3.883	   -­‐3.438	  
0.3	   -­‐2.198	   -­‐4.277	   -­‐2.210	   -­‐1.906	   -­‐4.166	   -­‐0.777	   -­‐3.185	   -­‐1.960	   -­‐6.532	  
0.3	   -­‐2.791	   -­‐4.554	   -­‐2.541	   -­‐1.939	   -­‐4.193	   -­‐0.747	   -­‐2.821	   -­‐3.052	   -­‐5.582	  
0.3	   -­‐2.815	   -­‐4.500	   -­‐1.978	   -­‐1.890	   -­‐4.067	   -­‐0.852	   -­‐3.215	   -­‐2.646	   -­‐5.569	  
0.2	   -­‐3.658	   -­‐4.862	   -­‐2.339	   -­‐1.896	   -­‐4.193	   -­‐0.849	   -­‐3.034	   -­‐3.233	   -­‐6.854	  
0.2	   -­‐3.390	   -­‐4.780	   -­‐2.724	   -­‐1.951	   -­‐4.220	   -­‐0.873	   -­‐3.134	   -­‐3.311	   -­‐5.730	  
0.2	   -­‐3.209	   -­‐5.144	   -­‐2.974	   -­‐1.972	   -­‐4.423	   -­‐0.728	   -­‐2.917	   -­‐3.001	   -­‐3.700	  
0.2	   -­‐3.745	   -­‐5.106	   -­‐3.209	   -­‐2.161	   -­‐4.697	   -­‐0.816	   -­‐3.266	   -­‐2.992	   -­‐5.836	  
0.1	   -­‐3.513	   -­‐4.645	   -­‐2.757	   -­‐1.815	   -­‐4.106	   -­‐0.695	   -­‐2.980	   -­‐2.616	   -­‐4.750	  
0.1	   -­‐3.104	   -­‐4.924	   -­‐2.667	   -­‐1.851	   -­‐4.175	   -­‐0.858	   -­‐3.176	   -­‐2.589	   -­‐6.830	  
0.1	   -­‐3.706	   -­‐4.928	   -­‐3.287	   -­‐1.830	   -­‐4.136	   -­‐0.629	   -­‐2.827	   -­‐2.779	   -­‐6.943	  
0.1	   -­‐3.251	   -­‐4.726	   -­‐2.616	   -­‐1.990	   -­‐4.094	   -­‐0.780	   -­‐3.260	   -­‐2.782	   -­‐6.947	  
0	   -­‐3.043	   -­‐4.413	   -­‐3.031	   -­‐2.005	   -­‐5.770	   -­‐0.951	   -­‐3.414	   -­‐2.733	   -­‐5.455	  
0	   -­‐3.335	   -­‐4.211	   -­‐3.140	   -­‐1.930	   -­‐5.493	   -­‐0.798	   -­‐3.224	   -­‐2.649	   -­‐5.292	  
0	   -­‐3.977	   -­‐4.762	   -­‐3.025	   -­‐1.803	   -­‐3.962	   -­‐0.617	   -­‐2.995	   -­‐3.031	   -­‐5.693	  
0	   -­‐3.456	   -­‐4.889	   -­‐3.209	   -­‐2.047	   -­‐3.874	   -­‐0.735	   -­‐3.266	   -­‐2.926	   -­‐3.600	  
1	   -­‐3.161	   -­‐3.733	   -­‐1.424	   -­‐5.178	   -­‐5.825	   -­‐2.477	   -­‐4.452	   -­‐4.534	   -­‐6.668	  
1	   -­‐2.779	   -­‐4.615	   -­‐3.299	   -­‐5.714	   -­‐4.028	   -­‐2.339	   -­‐5.714	   -­‐4.362	   -­‐5.714	  
1	   -­‐1.364	   -­‐3.049	   -­‐1.189	   -­‐3.784	   -­‐5.933	   -­‐2.628	   -­‐4.142	   -­‐3.335	   -­‐5.933	  
0.75	   -­‐1.782	   -­‐3.372	   -­‐1.261	   -­‐1.225	   -­‐6.322	   -­‐1.331	   -­‐2.917	   -­‐3.236	   -­‐6.322	  
0.75	   -­‐2.471	   -­‐4.109	   -­‐2.285	   -­‐2.402	   -­‐5.915	   -­‐1.629	   -­‐3.236	   -­‐3.152	   -­‐5.915	  
0.75	   -­‐1.800	   -­‐3.883	   -­‐0.993	   -­‐1.662	   -­‐6.201	   -­‐1.451	   -­‐3.049	   -­‐3.531	   -­‐6.201	  
0.75	   -­‐2.255	   -­‐3.670	   -­‐1.325	   -­‐2.179	   -­‐5.674	   -­‐1.686	   -­‐2.682	   -­‐3.055	   -­‐5.674	  
0.75	   -­‐0.960	   -­‐3.673	   -­‐0.795	   -­‐1.129	   -­‐4.928	   -­‐1.189	   -­‐2.797	   -­‐3.098	   -­‐6.114	  
0.75	   -­‐1.833	   -­‐3.212	   -­‐1.731	   -­‐1.933	   -­‐4.386	   -­‐1.352	   -­‐2.947	   -­‐2.565	   -­‐5.084	  
0.5	   -­‐1.457	   -­‐2.995	   -­‐1.045	   -­‐1.075	   -­‐5.551	   -­‐1.036	   -­‐2.613	   -­‐2.935	   -­‐6.138	  
0.5	   -­‐2.198	   -­‐2.935	   -­‐1.999	   -­‐1.716	   -­‐4.389	   -­‐1.430	   -­‐2.860	   -­‐2.387	   -­‐5.497	  
0.5	   -­‐1.614	   -­‐3.661	   -­‐1.171	   -­‐1.331	   -­‐4.657	   -­‐1.060	   -­‐2.342	   -­‐2.640	   -­‐5.990	  
0.5	   -­‐1.358	   -­‐3.031	   -­‐1.529	   -­‐1.993	   -­‐4.392	   -­‐1.520	   -­‐3.013	   -­‐2.420	   -­‐5.443	  
0.5	   -­‐0.912	   -­‐2.670	   -­‐0.569	   -­‐1.322	   -­‐4.877	   -­‐1.240	   -­‐2.763	   -­‐2.839	   -­‐4.973	  
0.5	   -­‐1.427	   -­‐2.324	   -­‐1.421	   -­‐2.128	   -­‐4.184	   -­‐1.710	   -­‐2.962	   -­‐1.767	   -­‐4.395	  
0.25	   0.449	   0.569	   -­‐0.668	   -­‐0.810	   -­‐4.518	   -­‐0.918	   -­‐2.351	   -­‐2.432	   -­‐6.490	  
0.25	   -­‐2.312	   -­‐2.520	   -­‐1.830	   -­‐1.713	   -­‐4.121	   -­‐1.349	   -­‐2.742	   -­‐2.110	   -­‐4.741	  
0.25	   -­‐1.538	   -­‐2.234	   -­‐0.819	   -­‐0.990	   -­‐4.570	   -­‐0.996	   -­‐2.414	   -­‐2.357	   -­‐5.078	  
0.25	   -­‐2.246	   -­‐1.797	   -­‐1.737	   -­‐1.713	   -­‐3.302	   -­‐1.448	   -­‐2.839	   -­‐1.445	   -­‐4.208	  
0.25	   -­‐2.285	   -­‐3.633	   -­‐2.053	   -­‐1.623	   -­‐3.953	   -­‐1.665	   -­‐2.535	   -­‐2.745	   -­‐5.756	  
0.25	   -­‐2.264	   -­‐2.447	   -­‐1.568	   -­‐1.710	   -­‐3.630	   -­‐1.373	   -­‐2.908	   -­‐2.095	   -­‐5.136	  
0	   -­‐1.273	   -­‐2.652	   -­‐2.128	   -­‐0.701	   -­‐4.022	   -­‐1.066	   -­‐2.586	   -­‐2.330	   -­‐6.033	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0	   -­‐2.056	   -­‐1.746	   -­‐2.676	   -­‐2.155	   -­‐3.995	   -­‐1.692	   -­‐2.682	   -­‐1.770	   -­‐4.067	  
0	   -­‐2.167	   -­‐3.594	   -­‐1.948	   -­‐1.337	   -­‐4.383	   -­‐1.150	   -­‐2.625	   -­‐2.944	   -­‐6.304	  
0	   -­‐2.559	   -­‐2.779	   -­‐2.125	   -­‐1.385	   -­‐4.678	   -­‐1.394	   -­‐2.757	   -­‐2.520	   -­‐5.090	  
0	   -­‐2.089	   -­‐2.709	   -­‐1.945	   -­‐1.316	   -­‐4.127	   -­‐1.379	   -­‐2.631	   -­‐2.155	   -­‐4.985	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Appendix	  D.	  Log	  normalized	  gene	  expression	  over	  GAPDH	  test	  data	  
Composition	   ASPHD2	   CCL19	   XAF1	   CCL26	   CLEC4G	   ALOX15	   PLCB1	   RAMP1	   WNT5B	  
1	   -­‐0.358	   -­‐2.920	   -­‐0.129	   -­‐3.007	   -­‐4.040	   -­‐3.227	   -­‐3.591	   -­‐1.824	   -­‐6.087	  
1	   -­‐1.234	   -­‐2.974	   0.759	   -­‐3.080	   -­‐3.925	   -­‐2.610	   -­‐2.742	   -­‐1.189	   -­‐5.632	  
1	   -­‐0.777	   -­‐3.233	   -­‐0.135	   -­‐3.116	   -­‐3.971	   -­‐3.080	   -­‐3.363	   -­‐1.818	   -­‐6.364	  
1	   -­‐1.171	   -­‐3.215	   -­‐1.011	   -­‐2.315	   -­‐3.164	   -­‐3.694	   -­‐3.691	   -­‐1.406	   -­‐6.078	  
0.75	   -­‐1.535	   -­‐3.137	   -­‐0.467	   -­‐1.562	   -­‐4.717	   -­‐1.827	   -­‐2.968	   -­‐2.493	   -­‐6.186	  
0.75	   -­‐1.604	   -­‐3.980	   -­‐1.120	   -­‐1.993	   -­‐4.064	   -­‐2.336	   -­‐3.278	   -­‐2.300	   -­‐6.370	  
0.75	   -­‐1.653	   -­‐3.679	   -­‐0.539	   -­‐1.767	   -­‐4.010	   -­‐2.170	   -­‐3.049	   -­‐2.167	   -­‐6.556	  
0.75	   -­‐1.632	   -­‐3.808	   -­‐1.201	   -­‐2.149	   -­‐3.871	   -­‐2.390	   -­‐3.411	   -­‐2.216	   -­‐6.355	  
0.5	   -­‐1.574	   -­‐3.558	   -­‐0.969	   -­‐1.346	   -­‐4.100	   -­‐1.927	   -­‐2.890	   -­‐1.951	   -­‐6.219	  
0.5	   -­‐1.325	   -­‐2.974	   -­‐1.553	   -­‐1.999	   -­‐3.335	   -­‐2.321	   -­‐3.287	   -­‐1.126	   -­‐5.331	  
0.5	   -­‐1.881	   -­‐3.947	   -­‐1.078	   -­‐1.096	   -­‐4.503	   -­‐1.267	   -­‐2.628	   -­‐2.372	   -­‐6.478	  
0.5	   -­‐2.330	   -­‐4.130	   -­‐1.872	   -­‐1.698	   -­‐4.419	   -­‐2.023	   -­‐3.061	   -­‐2.499	   -­‐6.478	  
0.25	   -­‐2.420	   -­‐4.208	   -­‐1.084	   -­‐1.463	   -­‐4.952	   -­‐1.674	   -­‐2.911	   -­‐2.851	   -­‐6.596	  
0.25	   -­‐2.053	   -­‐4.040	   -­‐1.556	   -­‐1.731	   -­‐4.254	   -­‐2.143	   -­‐3.173	   -­‐2.357	   -­‐6.352	  
0.25	   -­‐2.658	   -­‐4.476	   -­‐1.255	   -­‐1.108	   -­‐5.488	   -­‐1.752	   -­‐2.887	   -­‐2.760	   -­‐5.997	  
0.25	   -­‐2.604	   -­‐4.350	   -­‐2.017	   -­‐1.577	   -­‐4.552	   -­‐2.023	   -­‐2.935	   -­‐2.748	   -­‐5.828	  
0	   -­‐2.240	   -­‐4.455	   -­‐2.125	   -­‐1.701	   -­‐5.102	   -­‐2.176	   -­‐2.932	   -­‐2.932	   -­‐6.370	  
0	   -­‐2.119	   -­‐4.127	   -­‐2.146	   -­‐1.872	   -­‐4.651	   -­‐1.960	   -­‐2.956	   -­‐2.207	   -­‐5.057	  
0	   -­‐1.779	   -­‐4.037	   -­‐1.794	   -­‐1.312	   -­‐4.121	   -­‐1.364	   -­‐2.592	   -­‐2.122	   -­‐6.571	  
0	   -­‐1.927	   -­‐3.594	   -­‐2.294	   -­‐1.499	   -­‐3.760	   -­‐1.836	   -­‐2.866	   -­‐1.939	   -­‐5.813	  
	  
	  
